Microbicidal Inducer
Alkoxypyridazine derivatives are developed as agrochemicals to combat fungal diseases in plants and non-living materials, providing effective fungal control with low application rates and environmental safety.
Patent Information
- Application Number
- JP2021570470
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-05-29
- Filing Date
- 2020-05-27
- Publication Date
- 2024-11-27
- Estimated Expiration
- 2040-05-27
AI Technical Summary
Existing agrochemicals are ineffective in providing adequate protection against fungal diseases in plants, particularly in harvested food crops, seeds, and non-living materials.
Development of microbicidal pyrazine derivatives, specifically alkoxypyridazine compounds, which exhibit fungicidal activity and are formulated into agrochemical compositions for application on plants and habitats to control phytopathogenic microorganisms.
The alkoxypyridazine derivatives demonstrate high biological activity in protecting plants from fungal diseases, offering good activity at low application rates, high plant tolerability, and environmental safety, while effectively inhibiting fungal growth and preventing infestations.
Smart Images

Figure 0007590993000001 
Figure 0007590993000002 
Figure 0007590993000003
Abstract
Description
[Technical field]
[0001] The present invention relates to microbicidal pyrazine derivatives, in particular alkoxypyridazine derivatives, for example as active ingredients having microbicidal activity, in particular fungicidal and fungicidal activity, and also to the preparation of these pyridazine derivatives, to agrochemical compositions comprising at least one of the pyridazine derivatives and to the use of the pyridazine derivatives or compositions thereof in agriculture or horticulture for controlling or preventing infestation by phytopathogenic microorganisms, preferably fungi, on plants, harvested food crops, seeds or non-living materials. [Background technology]
[0002] WO 2010 / 012793 and WO 2017 / 207362 describe thiazole derivatives as pesticides. Summary of the Invention [Means for solving the problem]
[0003] According to the present invention, a compound of formula (I): [ka] (In the formula, R 1 is hydrogen, cyano, formyl, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 alkoxyC1-C6 alkylcarbonyl, C3-C6 cycloalkylcarbonyl, C1-C6 alkoxyC1-C3 alkoxycarbonyl, C1-C6 alkoxyoxalyl, C1-C6 alkoxycarbonyl C1-C4 alkylC1-C6 alkoxycarbonyl, C2-C6 alkenyloxycarbonyl or C2-C6 alkynyloxycarbonyl; R 2is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, halogen, hydroxy, C1-C6 alkoxy, C1-C6 haloalkoxy, C3-C6 cycloalkyloxy, C3-C6 halocycloalkyloxy, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C1-C6 cyanoalkyloxy, C1-C6 alkoxyC1-C3 alkoxy, C1-C6 alkoxyC1-C2 alkyl, C2-C6 alkynyl, C2-C6 haloalkynyl or C3-C6 cycloalkylC1-C2 alkoxy; R 3 is C1-C8 alkyl, C1-C8 haloalkyl, C1-C8 alkoxy, C3-C8 alkynyl, C3-C8 cycloalkyl, C3-C8 cycloalkylC1-C2 alkyl, phenyl, phenylC1-C3 alkyl, phenoxyC1-C3 alkyl, heteroaryl, heteroarylC1-C2 alkyl, heteroarylC1-C2 alkoxyiminoC1-C2 alkyl (wherein heteroaryl is a 5- or 6-membered aromatic monocyclic ring containing 1, 2, 3 or 4 heteroatoms individually selected from N, O and S), heterocyclyl, heterocyclylC1-C2 alkyl (wherein heterocyclyl is a 4-, 5- or 6-membered non-aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S), where the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are R 5 or R 6 each optionally substituted with one group represented by 3 is a substituted heterocyclyl, these rings may contain carbonyl (C=O) or sulfonyl (S(O)2) groups; or R 3 is a 6-10 membered annulated ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N, O and S; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker; or R 3 is a 5-10 membered non-aromatic spirocyclic carbobicyclyl or carbotricyclyl ring system, optionally containing 1, 2, 3, 4 or 5 heteroatoms individually selected from N, O and S; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker; R 4 is C1-C8 alkyl, hydroxyC1-C8 alkyl, C3-C8 cycloalkyl, C3-C8 cycloalkylC1-C2 alkyl, phenyl, heteroaryl which is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S, heterocyclyl which is a 4-, 5- or 6-membered non-aromatic monocyclic ring or a 9- to 10-membered non-aromatic bicyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S, where the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are R 8 each optionally substituted with 1, 2 or 3 substituents, which may be the same or different, selected from R 5 is halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl or C1-C4 haloalkoxy; R 6 is C1-C4 alkylsulfonyl, C3-C8 cycloalkyl, phenyl, benzyl, phenoxy, or pyridyl, where each cycloalkyl, phenyl, or pyridyl group is independently selected from R 7 and optionally substituted with one group represented by R 7 is halogen, C1-C4 haloalkyl, or C1-C4 haloalkoxy; R 8 is halogen, C1-C4 alkyl, C1-C4 alkoxy or C1-C4 haloalkyl or a salt or N-oxide thereof.
[0004] Surprisingly, it has now been found that the novel compounds of formula (I) have a very advantageous level of biological activity for protecting plants against diseases caused by fungi in fact.
[0005] According to a second aspect of the present invention there is provided an agrochemical composition comprising a fungicidally effective amount of a compound of formula (I) according to the present invention, which may further comprise at least one additional active ingredient and / or an agrochemically acceptable diluent or carrier.
[0006] According to a third aspect of the present invention there is provided a method for controlling or preventing infestation of useful plants by phytopathogenic microorganisms, which comprises applying a fungicidally effective amount of a compound of formula (I) or a composition comprising this compound as an active ingredient to the plant, its part or its habitat.
[0007] According to a fourth aspect of the present invention there is provided the use of a compound of formula (I) as a bactericide or fungicide. According to this particular aspect of the present invention the use may or may not include a method of treating the human or animal body by surgery or therapy.
[0008] When substituents are described as being "optionally substituted," this means that these substituents may be, for example, one, two, or three R 5 It means that the alkyl group may or may not have one or more identical or different substituents such as aryl, ... DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0009] As used herein, the term "cyano" refers to a -CN group.
[0010] As used herein, the term "halogen" refers to fluorine (fluoro), chlorine (chloro), bromine (bromo) or iodine (iodo).
[0011] As used herein, the term "formyl" means a -C(O)H group.
[0012] As used herein, the term "acetyl" refers to a -C(O)CH group.
[0013] As used herein, the term "C1-C8 alkyl" refers to a straight or branched hydrocarbon chain radical consisting only of carbon and hydrogen atoms, containing no unsaturation, having 1-8 carbon atoms, and attached to the remainder of the molecule by a single bond. "C1-C6 alkyl", "C1-C4 alkyl" and "C1-C3 alkyl" should be construed accordingly. Examples of C1-C8 alkyl include, but are not limited to, methyl, ethyl, n-propyl and its isomers, such as isopropyl. A "C1-C6 alkylene" group refers to the corresponding definition of C1-C6 alkyl, except that such group is attached to the remainder of the molecule by two single bonds. The term "C1-C2 alkylene" should be construed accordingly. Examples of C1-C6 alkylene include, but are not limited to, -CH2-, -CH2CH2- and -(CH2)3-.
[0014] As used herein, the term "C1-C8 haloalkyl" refers to a C1-C8 alkyl group, as generally defined above, substituted by one or more identical or different halogen atoms. The terms "C1-C6 haloalkyl" and "C1-C4 haloalkyl" should be interpreted accordingly. Examples of C1-C8 haloalkyl include, but are not limited to, trifluoromethyl.
[0015] As used herein, the term "C1-C8 alkoxy" refers to any group represented by R a is a C1-C8 alkyl group of the formula -OR a The terms "C1-C6 alkoxy", "C1-C4 alkoxy" and "C1-C3 alkoxy" should be construed accordingly. Examples of C1-C8 alkoxy include, but are not limited to, methoxy, ethoxy, 1-methylethoxy (isopropoxy) and propoxy.
[0016] As used herein, the term "C2-C6 alkenyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one double bond that may be in either the (E) or (Z) configuration, having 2 to 6 carbon atoms, and attached to the remainder of the molecule by a single bond. The term "C2-C3 alkenyl" should be construed accordingly. Examples of C2-C6 alkenyl include, but are not limited to, ethenyl (vinyl), prop-1-enyl, prop-2-enyl (allyl), and but-1-enyl.
[0017] As used herein, the term "C2-C6 alkenyloxy" refers to any of R a is a C2-C8 alkenyl group; a Refers to the group.
[0018] As used herein, the term "C2-C6 alkynyl" refers to a straight or branched hydrocarbon chain radical group consisting solely of carbon and hydrogen atoms, containing at least one triple bond, having 2-6 carbon atoms, and attached to the remainder of the molecule by a single bond. The term "C2-C3 alkynyl" should be construed accordingly. Examples of C2-C6 alkynyl include, but are not limited to, ethynyl, prop-1-ynyl, but-1-ynyl.
[0019] As used herein, the term "C2-C6 alkynyloxy" refers to any of R a is a C2-C8 alkynyl group of the formula -OR a Refers to the group.
[0020] As used herein, the term "C3-C8 cycloalkyl" refers to a group that is a monocyclic saturated ring system and has 3 to 8 carbon atoms. The terms "C3-C6 cycloalkyl" and "C3-C4 cycloalkyl" should be interpreted accordingly. Examples of C3-C6 cycloalkyl include, but are not limited to, cyclopropyl, 1-methylcyclopropyl, 2-methylcyclopropyl, cyclobutyl, 1-methylcyclobutyl, 1,1-dimethylcyclobutyl, 2-methylcyclobutyl, and 2,2-dimethylcyclobutyl.
[0021] As used herein, the term "C3-C8 cycloalkyl C1-C2 alkyl" refers to a C3-C8 cycloalkyl ring, as defined above, attached to the remainder of the molecule by a C1-C2 alkylene linker.
[0022] As used herein, the term "phenyl C1-C3 alkyl" refers to a phenyl ring, as defined above, attached to the remainder of the molecule by a C1-C3 alkylene linker.
[0023] As used herein, the term "heteroaryl" refers to a 5- or 6-membered aromatic monocyclic ring group containing 1, 2, 3, or 4 heteroatoms individually selected from N, O, and S. Examples of heteroaryl include, but are not limited to, furanyl, pyrrolyl, thienyl, pyrazolyl, imidazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, triazolyl, tetrazolyl, pyrazinyl, pyridazinyl, pyrimidyl, or pyridyl.
[0024] As used herein, the term "heteroaryl C1-C2 alkyl" refers to a heteroaryl ring, as defined above, attached to the remainder of the molecule by a C1-C2 alkylene linker.
[0025] As used herein, the term "heterocyclyl" refers to a stable 4-, 5-, or 6-membered non-aromatic monocyclic ring containing one, two, or three heteroatoms, where the heteroatoms are individually selected from N, O, and S. The heterocyclyl group can be attached to the remainder of the molecule through a carbon atom or a heteroatom. Examples of heterocyclyl include, but are not limited to, aziridinyl, azetidinyl, oxetanyl, thietanyl, tetrahydrofuryl, pyrrolidinyl, pyrazolidinyl, imidazolidinyl, piperidinyl, piperazinyl, morpholinyl, dioxolanyl, dithiolanyl, and thiazolidinyl.
[0026] As used herein, the term "heterocyclylC1-C2 alkyl" refers to a heterocyclyl ring, as defined above, attached to the remainder of the molecule by a C1-C2 alkylene linker.
[0027] As used herein, a "spirocyclic carbobicyclyl or carbotricyclyl ring" is a non-aromatic bicyclic ring system containing two rings joined together at one carbon atom (i.e., sharing one carbon atom). Examples of spirocyclic carbobicyclyl or carbotricyclyl ring systems include, but are not limited to, spiro[3.3]heptanyl, spiro[3.4]octanyl, spiro[4.5]decanyl, spiro[cyclobutane-1,2'-indanyl], or spiro[cyclopentane-1,2'-tetralinyl].
[0028] As used herein, the term "C1-C6 alkylcarbonyl" refers to any of R a is a C1-C6 alkyl group of the formula -C(O)R a Refers to the group.
[0029] As used herein, the term "C1-C6 alkoxyC1-C6 alkylcarbonyl" refers to any of R b is a C1-C6 alkyl group, and R a is a C1-C6 alkylene group of the formula -C(O)R a OR b Refers to the group.
[0030] As used herein, the term "C1-C6 haloalkylcarbonyl" refers to any of R a is a C1-C6 haloalkyl group of the formula -C(O)R a Refers to the group.
[0031] As used herein, the term "C-C cycloalkylcarbonyl" refers to any of R a is a C3-C6 cycloalkyl group of the formula -C(O)R a Refers to the group.
[0032] As used herein, the term "C1-C6 alkoxycarbonyl" refers to any of R a is a C1-C6 alkyl group of the formula -C(O)OR a Refers to the group.
[0033] As used herein, the term "C1-C6 alkoxyoxalyl" refers to any of R a -C(O)C(O)OR is a C1-C6 alkyl group a Refers to the base.
[0034] As used herein, the term "C2-C6 alkenyloxycarbonyl" refers to any of R a is a C2-C6 alkenyl group of the formula -C(O)OR a Refers to the group.
[0035] As used herein, the term "C2-C6 alkynyloxycarbonyl" refers to any of R a is a C2-C6 alkynyl group of the formula -C(O)OR a Refers to the group.
[0036] As used herein, the term “phenylcarbonyl” refers to R a is a phenyl group of the formula -C(O)R a Refers to the group.
[0037] As used herein, the term “phenoxycarbonyl” refers to R a is a phenyl group of the formula -C(O)OR a Refers to the group.
[0038] As used herein, the term "heteroarylcarbonyl" refers to any group consisting of R a is a heteroaryl group of the formula -C(O)R a Refers to the group.
[0039] The possibility of the presence of one or more stereochemical elements in the compound of formula (I) means that the compound can be in optical isomeric form, i.e., enantiomeric or diastereomeric form. Also, atropisomers can occur due to the restriction of rotation about a single bond. Formula (I) is intended to include all these possible isomeric forms and mixtures thereof. The present invention includes all these possible isomeric forms and mixtures thereof for the compound of formula (I). Similarly, formula (I) is intended to include all possible tautomeric forms. The present invention includes all possible tautomeric forms for the compound of formula (I).
[0040] In each case, the compounds of formula (I) according to the invention may be in free form, in oxidized form as N-oxides or in salt form, for example in agriculturally usable salt form.
[0041] N-oxides are the oxidized forms of tertiary amines or nitrogen-containing aromatic heterocyclic compounds. They are described, for example, in the book "Heterocyclic N-oxides", A. Albini and S. Pietra, CRC Press, Boca Raton (1991).
[0042] The following list identifies the substituents R with reference to compounds of formula (I): 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 Definitions are provided below, including preferred definitions for: For any one of these substituents, any of the definitions given below may be combined with any of the definitions of any other substituents given below or elsewhere in this specification.
[0043] R 1is hydrogen, cyano, formyl, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 alkoxyC1-C6 alkylcarbonyl, C3-C6 cycloalkylcarbonyl, C1-C6 alkoxyC1-C3 alkoxycarbonyl, C1-C6 alkoxyoxalyl, C1-C6 alkoxycarbonylC1-C4 alkylC1-C6 alkoxycarbonyl, C2-C6 alkenyloxycarbonyl or C2-C6 alkynyloxycarbonyl. Preferably, R 1 is hydrogen, cyano, C1-C6 alkylcarbonyl, C1-C4 alkoxycarbonyl, C1-C4 haloalkylcarbonyl, C1-C4 alkoxyC1-C3 alkylcarbonyl, C3-C6 cycloalkylcarbonyl, C1-C4 alkoxyC1-C2 alkoxycarbonyl, C2-C4 alkenyloxycarbonyl or C2-C4 alkynyloxycarbonyl. More preferably, R 1 is hydrogen, cyano, C1-C6 alkylcarbonyl or C1-C4 alkoxyC1-C3 alkylcarbonyl. Even more preferably, R 1 is hydrogen, cyano, C1-C3 alkylcarbonyl or C1-C2 alkoxy C1-C2 alkylcarbonyl. Even more preferably, R 1 is hydrogen, cyano, acetyl or methoxymethylcarbonyl. Even more preferably, R 1 is hydrogen, cyano or acetyl. Most preferably, R 1 is hydrogen.
[0044] R 2is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, halogen, hydroxy, C1-C6 alkoxy, C1-C6 haloalkoxy, C3-C6 cycloalkyloxy, C3-C6 halocycloalkyloxy, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C1-C6 cyanoalkyloxy, C1-C6 alkoxyC1-C3 alkoxy, C1-C6 alkoxyC1-C2 alkyl, C2-C6 alkynyl, C2-C6 haloalkynyl, or C3-C6 cycloalkylC1-C2 alkoxy. Preferably, R 2 is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, halogen, hydroxy, C1-C6 alkoxy, C1-C6 haloalkoxy, C3-C6 cycloalkyloxy, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C1-C6 alkoxyC1-C3 alkoxy, C1-C6 alkoxyC1-C2 alkyl, C2-C6 alkynyl, or C2-C6 haloalkynyl. More preferably, R 2 is hydrogen, C1-C6 alkyl, C1-C4 haloalkyl, halogen, hydroxy, C1-C6 alkoxy, C1-C3 haloalkoxy, C3-C6 cycloalkyloxy, C2-C5 alkenyloxy, C2-C5 haloalkenyloxy, C2-C5 alkynyloxy, C1-C4 alkoxyC1-C3 alkoxy, C1-C4 alkoxyC1-C2 alkyl or C2-C5 alkynyl. Even more preferably, R 2 is hydrogen, C1-C4 alkyl, C1-C3 haloalkyl, halogen, hydroxy, C1-C4 alkoxy, C1-C3 haloalkoxy, C3-C4 cycloalkoxy, C3-C4 alkenyloxy, C3-C4 alkynyloxy, C1-C2 alkoxy C1-C2 alkoxy, C1-C2 alkoxy C1-C2 alkyl, C1-C3 haloalkoxy or C3-C5 alkynyl. Even more preferably, R 2 is hydrogen, C1-C4 alkyl, halogen, C1-C4 alkoxy, C1-C3 haloalkoxy or cyclopropoxy. Even more preferably, R 2is hydrogen, methyl, chloro, bromo, fluoro, methoxy, ethoxy, isopropoxy, allyloxy, propargyloxy, difluoromethoxy, trifluoromethoxy or cyclopropoxy. Even more preferably, R 2 is hydrogen, methyl or methoxy. Most preferably, R 2 is methoxy.
[0045] R 3 is C1-C8 alkyl, C1-C8 haloalkyl, C1-C8 alkoxy, C3-C8 alkynyl, C3-C8 cycloalkyl, C3-C8 cycloalkylC1-C2 alkyl, phenyl, phenylC1-C3 alkyl, phenoxyC1-C3 alkyl, heteroaryl, heteroarylC1-C2 alkyl, heteroarylC1-C2 alkoxyiminoC1-C2 alkyl (wherein heteroaryl is a 5- or 6-membered aromatic monocyclic ring containing 1, 2, 3 or 4 heteroatoms individually selected from N, O and S), heterocyclyl, heterocyclylC1-C2 alkyl (wherein heterocyclyl is a 4-, 5- or 6-membered non-aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S), where the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are R 5 or R 6 each optionally substituted with one group represented by 3 is a substituted heterocyclyl, these rings may contain carbonyl (C=O) or sulfonyl (S(O)2) groups; or R 3 is a 6-10 membered annulated ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N, O and S; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker; or R 3is a 5-10 membered non-aromatic spirocyclic carbobicyclyl or carbotricyclyl ring system, optionally containing 1, 2, 3, 4 or 5 heteroatoms individually selected from N, O and S; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker.
[0046] Preferably, R 3 is C1-C8 alkyl, C3-C8 alkynyl, C3-C8 cycloalkyl, C3-C8 cycloalkylC1-C2 alkyl, phenylC1-C3 alkyl, phenoxyC1-C3 alkyl, heteroaryl, heteroarylC1-C2 alkyl, heteroarylC1-C2 alkoxyiminoC1-C2 alkyl (wherein heteroaryl is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S), heterocyclyl, heterocyclylC1-C2 alkyl (wherein heterocyclyl is a 5- or 6-membered non-aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S), where the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are R 5 or R 6 each optionally substituted with one group represented by 3 is a substituted heterocyclyl, these rings may contain carbonyl (C=O) or sulfonyl (S(O)2) groups; or R 3 is a 7-10 membered annulated ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N, O and S; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker; or R 3is a 6-10 membered non-aromatic spirocyclic carbobicyclyl or carbotricyclyl ring system, optionally containing 1, 2, 3, 4 or 5 heteroatoms individually selected from N, O and S; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker.
[0047] More preferably, R 3 is C1-C8 alkyl, C3-C8 alkynyl, C3-C6 cycloalkyl, C3-C6 cycloalkylC1-C2 alkyl, phenylC1-C3 alkyl, phenoxyC1-C3 alkyl, heteroaryl, heteroarylC1-C2 alkyl, heteroarylC1-C2 alkoxyiminoC1-C2 alkyl (wherein heteroaryl is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N and O), heterocyclyl, heterocyclylC1-C2 alkyl (wherein heterocyclyl is a 5- or 6-membered non-aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S), where the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are R 5 or R 6 each optionally substituted with one group represented by 3 is a substituted heterocyclyl, these rings may contain carbonyl (C=O) or sulfonyl (S(O)2) groups; or R 3 is a 7-9 membered annulated ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N and O; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker; or R 3is a 6-9 membered non-aromatic spirocyclic carbobicyclyl ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N and O; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker.
[0048] Even more preferably, R 3 is C1-C8 alkyl, C3-C7 alkynyl, C3-C4 cycloalkyl, C3-C4 cycloalkylC1-C2 alkyl, phenylC1-C3 alkyl, phenoxyC1-C3 alkyl, heteroaryl, heteroarylC1-C2 alkyl, heteroarylC1-C2 alkoxyiminoC1-C2 alkyl (wherein heteroaryl is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N and O), heterocyclyl, heterocyclylC1-C2 alkyl (wherein heterocyclyl is a 5- or 6-membered non-aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S), where the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are R 5 or one or two groups represented by 6 each optionally substituted with one group represented by 3 is a substituted heterocyclyl, these rings may contain carbonyl (C=O) or sulfonyl (S(O)2) groups; or R 3 is a 7-9 membered annulated ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N and O; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker; or R 3is a 6-9 membered non-aromatic spirocyclic carbobicyclyl ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N and O; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker.
[0049] Even more preferably, R 3 is t-butyl, isopentyl, 2,2-dimethylpropyl, 1,5-dimethylhexyl, 4,4-dimethylpent-2-ynyl, R 5 or R 6 cyclopropyl, optionally substituted with one group represented by 5 or one or two groups represented by 6 cyclobutyl, optionally substituted with one group represented by 5 or R 6 cyclopropylmethyl, optionally substituted with one group represented by 5 or one or two groups represented by 6 Phenyl C1-C3 alkyl optionally substituted with one group represented by 6 Phenoxy C1-C3 alkyl, heteroaryl C1-C2 alkyl, heteroaryl C1-C2 alkoxyimino C1-C2 alkyl, optionally substituted with one or two groups represented by the formula: 5 or one or two groups represented by 6(heterocyclyl is a 5- or 6-membered non-aromatic monocyclic ring containing a single heteroatom selected from N and O; heterocyclylC1-C2 alkyl (heterocyclyl is a 5- or 6-membered non-aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N and O, and the heterocyclyl moiety is R 5 or R 6 each optionally substituted with one group represented by 3 is a substituted heterocyclyl, these rings may contain carbonyl (C=O) or sulfonyl (S(O)2) groups; or R 3 is a 7-9 membered annulated ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N and O; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker; or R 3 is a 6-9 membered non-aromatic spirocyclic carbobicyclyl ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N and O; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker.
[0050] In one set of embodiments, R 3are t-butyl, isopentyl, 2,2-dimethylpropyl, 1,5-dimethylhexyl, 4,4-dimethylpent-2-ynyl, 1-methylcyclopropyl, 4-fluorophenylcyclopropyl, (4-chlorophenyl)methylcyclopropyl, 2,2-dimethylcyclobutyl, 1-methylcyclopentyl, 4-fluorophenoxycyclobutyl, 1-trifluoromethylcyclopropylmethyl, (5-(trifluoromethyl)-2-pyridyl)cyclopropylmethyl, (6-chloro-3-pyridyl)cyclopropylmethyl, Benzyl, phenoxybenzyl, phenylethyl, 4-trifluoromethoxyphenylethyl, 2-phenylpropyl, 4-chlorobenzyl, 3,5-difluorobenzyl, 4-fluorophenoxyethyl, 3,5-difluorophenoxy-1-methylethyl, 2,4-dichlorophenoxyethyl, benzylimidazol-4-yl, 4-(difluoromethyl)-1-methylpyrazol-3-ylmethyl, 3,5-dichloro-4-pyridylmethyl, 1-(5-methyloxazol-2-yl)ethyl, 2-trifluoromethylpyridyl mydin-5-yl, (3,5-dichloro-2-pyridyl)-2-ethoxyimino-ethyl, 1-isopropylsulfonyl-4-piperidinyl, 1,1-dioxothian-4-yl, 5-cyclopropyltetrahydrofuran-3-yl, 3-methyltetrahydrofuran-3-ylmethyl, 1-tetrahydropyran-4-ylethyl, 2-methyltriazol-4-ylmethyl, 5-(trifluoromethyl)indan-1-yl, 6-(trifluoromethyl)indan-1-yl, pyrazolo[1,5-a]pyridin-7-ylmethyl, 1-methylpyrazolo[3,4-b]pyridin-3-yl, 2,3-dihydrobenzofuran-3-ylmethyl, 2,2-difluoro-1,3-benzodioxol-4-ylmethyl, spiro[3.4]octan-3-yl, 8-methyl-5-oxaspiro[3.5]nonan-8-yl, 2-oxabicyclo[3.3]heptan-6-yl, 7,7-dimethyl-2-oxabicyclo[3.2.0]heptan-6-yl, 2-oxabicyclo[3.2.0]heptan-7-yl or 4-oxaspiro[2.3]heptan-6-yl.
[0051] More preferably, R3 are t-butyl, isopentyl, 2,2-dimethylpropyl, 1,5-dimethylhexyl, 1-methylcyclopropyl, 2,2-dimethylcyclobutyl, 1-methylcyclopentyl, 1-trifluoromethylcyclopropylmethyl, (5-(trifluoromethyl)-2-pyridyl)cyclopropylmethyl, phenoxybenzyl, 4-trifluoromethoxyphenylethyl, 3,5-dichloro-4-pyridylmethyl, (3,5-dichloro-2-pyridyl)-2-ethoxyimino-ethyl, 5-cyclopropyltetrahydrofuran-3-yl, 3-methyltetrahydrofuran-4-yl, 5-cyclopropyltetrahydrofuran-3-yl, 5-methyltetrahydrofuran-4 ... lan-3-ylmethyl, 5-(trifluoromethyl)indan-1-yl, 6-(trifluoromethyl)indan-1-yl, pyrazolo[1,5-a]pyridin-7-ylmethyl, 2,3-dihydrobenzofuran-3-ylmethyl, 2,2-difluoro-1,3-benzodioxol-4-ylmethyl, 8-methyl-5-oxaspiro[3.5]non-8-yl, 7,7-dimethyl-2-oxabicyclo[3.2.0]heptan-6-yl, 2-oxabicyclo[3.2.0]heptan-7-yl or 4-oxaspiro[2.3]heptan-6-yl.
[0052] Even more preferably, R 3 is t-butyl, isopentyl, 2,2-dimethylpropyl, 1-methylcyclopropyl, 2,2-dimethylcyclobutyl, 1-methylcyclopentyl or spiro[3.4]octan-3-yl.
[0053] In another set of embodiments, R 3are t-butyl, isopentyl, 2,2-dimethylpropyl, 1,5-dimethylhexyl, 4,4-dimethylpent-2-ynyl, 1-methylcyclopropyl, 4-fluorophenylcyclopropyl, (4-chlorophenyl)methylcyclopropyl, 2,2-dimethylcyclobutyl, 4-fluorophenoxycyclobutyl, 1-trifluoromethylcyclopropylmethyl, (5-(trifluoromethyl)-2-pyridyl)cyclopropylmethyl, (6-chloro-3-pyridyl)cyclopropylmethyl, benzyl, phenoxy Benzyl, phenylethyl, 4-trifluoromethoxyphenylethyl, 2-phenylpropyl, 4-chlorobenzyl, 3,5-difluorobenzyl, 4-fluorophenoxyethyl, 3,5-difluorophenoxy-1-methylethyl, 2,4-dichlorophenoxyethyl, benzylimidazol-4-yl, 4-(difluoromethyl)-1-methylpyrazol-3-ylmethyl, 3,5-dichloro-4-pyridylmethyl, 1-(5-methyloxazol-2-yl)ethyl, 2-trifluoromethylpyrimidin-5-yl , (3,5-dichloro-2-pyridyl)-2-ethoxyimino-ethyl, 1-isopropylsulfonyl-4-piperidinyl, 1,1-dioxothiane-4-yl, 5-cyclopropyltetrahydrofuran-3-yl, 3-methyltetrahydrofuran-3-ylmethyl, 1-tetrahydropyran-4-ylethyl, 2-methyltriazol-4-ylmethyl, 5-(trifluoromethyl)indan-1-yl, 6-(trifluoromethyl)indan-1-yl, pyrazolo[1,5-a]pyridin-7-ylmethyl, 1-methyl 2,3-dihydrobenzofuran-3-ylmethyl, 2,2-difluoro-1,3-benzodioxol-4-ylmethyl, spiro[3.4]octan-3-yl, 8-methyl-5-oxaspiro[3.5]nonan-8-yl, 2-oxabicyclo[3.3]heptan-6-yl, 7,7-dimethyl-2-oxabicyclo[3.2.0]heptan-6-yl, 2-oxabicyclo[3.2.0]heptan-7-yl or 4-oxaspiro[2.3]heptan-6-yl.
[0054] More preferably, R 3are t-butyl, isopentyl, 2,2-dimethylpropyl, 1,5-dimethylhexyl, 1-methylcyclopropyl, 2,2-dimethylcyclobutyl, 1-trifluoromethylcyclopropylmethyl, (5-(trifluoromethyl)-2-pyridyl)cyclopropylmethyl, phenoxybenzyl, 4-trifluoromethoxyphenylethyl, 3,5-dichloro-4-pyridylmethyl, (3,5-dichloro-2-pyridyl)-2-ethoxyimino-ethyl, 5-cyclopropyltetrahydrofuran-3-yl, 3-methyltetrahydrofuran-3-yl 2,3-dihydrobenzofuran-3-ylmethyl, 2,2-difluoro-1,3-benzodioxol-4-ylmethyl, 8-methyl-5-oxaspiro[3.5]nonan-8-yl, 7,7-dimethyl-2-oxabicyclo[3.2.0]heptan-6-yl, 2-oxabicyclo[3.2.0]heptan-7-yl or 4-oxaspiro[2.3]heptan-6-yl.
[0055] Even more preferably, R 3 is t-butyl, isopentyl, 2,2-dimethylpropyl, 1-methylcyclopropyl, 2,2-dimethylcyclobutyl or spiro[3.4]octan-3-yl.
[0056] R 4 is C1-C8 alkyl, hydroxyC1-C8 alkyl, C3-C8 cycloalkyl, C3-C8 cycloalkylC1-C2 alkyl, phenyl, heteroaryl which is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S, heterocyclyl which is a 4-, 5- or 6-membered non-aromatic monocyclic ring or a 9- to 10-membered non-aromatic bicyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S, where the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are R 8Each of the groups may be optionally substituted with 1, 2 or 3 substituents, which may be the same or different, selected from 4 is C1-C6 alkyl, hydroxyC1-C6 alkyl, C3-C6 cycloalkyl, C3-C6 cycloalkylC1-C2 alkyl, phenyl, heteroaryl which is a 5- or 6-membered aromatic monocyclic ring containing one or two heteroatoms individually selected from N, O and S, heterocyclyl which is a 5- or 6-membered non-aromatic monocyclic ring containing one or two heteroatoms individually selected from N, O and S, where the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are R 8 More preferably, R 4 is C1-C6 alkyl, hydroxyC1-C4 alkyl, C3-C5 cycloalkyl, C3-C4 cycloalkylC1-C2 alkyl, phenyl, heteroaryl, which is a 5- or 6-membered aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from N, O and S, where the cycloalkyl, phenyl and heteroaryl moieties are each independently selected from R 8 Even more preferably, R 4 is 2,3-dihydroxypropyl, C-C cycloalkyl, cyclopropylmethyl, cyclobutylmethyl, phenyl, or heteroaryl, which is a 5- or 6-membered aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from N and S, where the phenyl and heteroaryl moieties are R 8 Each may be optionally substituted with 1 or 2 substituents, which may be the same or different, selected from:
[0057] In one set of embodiments, R 4is 2,3-dihydroxypropyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclopropylmethyl, phenyl, 3-fluorophenyl, 3-chlorophenyl, 3-methylphenyl, 3-methoxyphenyl, 3,5-difluorophenyl, 3,5-dichlorophenyl, 3,5-dimethylphenyl, 3,5-dimethoxyphenyl, pyridin-4-yl, 2-fluoropyridin-4-yl, 2-chloropyridin-4-yl, 2,6-difluoropyridin-4-yl, 2,6-dichloropyridin-4-yl, pyridin-3-yl, 6-fluoropyridin-3-yl, 5-fluoropyridin-3-yl, 6-chloropyridin-3-yl, 5-chloropyridin-3-yl, isothiazol-4-yl, thiazol-2-yl, pyrimidin-5-yl, or 1,3-benzodioxol-5-yl. 4 is 2,3-dihydroxypropyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclopropylmethyl, phenyl, 3,5-difluorophenyl, 2-fluoropyridin-4-yl, 2,6-difluoropyridin-4-yl, 2-chloropyridin-4-yl, 2,6-difluoropyridin-4-yl, 5-fluoropyridin-3-yl, 6-fluoropyridin-3-yl, isothiazol-4-yl, thiazol-2-yl, pyrimidin-5-yl, or 1,3-benzodioxol-5-yl. 4 is 3,5-difluorophenyl, 2,6-difluoropyridin-4-yl or isothiazol-4-yl.
[0058] R 5 is halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl or C1-C4 haloalkoxy. 5 is halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl or C1-C3 haloalkoxy. More preferably, R 5 is halogen, C1-C3 alkyl, C1-C3 haloalkyl or C1-C3 haloalkoxy. Even more preferably, R 5is chloro, fluoro, methyl, difluoromethyl or trifluoromethyl. Even more preferably, R 5 is methyl.
[0059] R 6 is C1-C4 alkylsulfonyl, C3-C8 cycloalkyl, phenyl, benzyl, phenoxy, or pyridyl, where each cycloalkyl, phenyl, or pyridyl group is independently selected from R 7 Preferably, R 6 is C1-C3 alkylsulfonyl, C3-C6 cycloalkyl, phenyl, benzyl, phenoxy, or pyridyl, where each cycloalkyl, phenyl, or pyridyl group is independently selected from R 7 Even more preferably, R 6 is cyclopropyl, cyclohexyl, phenyl, benzyl, phenoxy or pyridyl, where each cycloalkyl, phenyl or pyridyl group is 7 Most preferably, R 6 is cyclopropyl, phenyl, phenoxy or pyridyl, where each cyclopropyl, phenyl or pyridyl group is 7 and optionally substituted with one group represented by:
[0060] R 7 is halogen, C1-C4 haloalkyl or C1-C4 haloalkoxy. 7 is halogen, C1-C3 haloalkyl or C1-C3 haloalkoxy. More preferably, R 7 is chloro, fluoro, trifluoromethyl or trifluoromethoxy. Most preferably, R 7 is trifluoromethoxy.
[0061] R 8 is halogen, C1-C4 alkyl, C1-C4 alkoxy or C1-C4 haloalkyl.8 is chloro, fluoro, C1-C3 alkyl, C1-C3 alkoxy or C1-C3 haloalkyl. More preferably, R 8 is chloro, fluoro, methyl, ethyl, n-propyl, isopropyl, methoxy, ethoxy, isopropoxy, difluoromethyl or trifluoromethyl. Even more preferably, R 8 is chloro, fluoro or methyl. Most preferably, R 8 is fluoro.
[0062] In the compound of formula (I) according to the present invention, R 1 is hydrogen, cyano, C1-C6 alkylcarbonyl, or C1-C4 alkoxyC1-C3 alkylcarbonyl; R 2 is methoxy; R 3 is C1-C8 alkyl, C3-C7 alkynyl, C3-C4 cycloalkyl, C3-C4 cycloalkylC1-C2 alkyl, phenylC1-C3 alkyl, phenoxyC1-C3 alkyl, heteroaryl, heteroarylC1-C2 alkyl, heteroarylC1-C2 alkoxyiminoC1-C2 alkyl (wherein heteroaryl is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N and O), heterocyclyl, heterocyclylC1-C2 alkyl (wherein heterocyclyl is a 5- or 6-membered non-aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S), where the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are R 5 or one or two groups represented by 6 each optionally substituted with one group represented by 3 is a substituted heterocyclyl, these rings may contain carbonyl (C=O) or sulfonyl (S(O)2) groups; or R 3is a 7-9 membered annulated ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N and O; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker; or R 3 is a 6-9 membered non-aromatic spirocyclic carbobicyclyl ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N and O; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker; R 4 is 2,3-dihydroxypropyl, C-C cycloalkyl, cyclopropylmethyl, cyclobutylmethyl, phenyl, or heteroaryl, which is a 5- or 6-membered aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from N and S, where the phenyl and heteroaryl moieties are R 8 each optionally substituted with 1 or 2 substituents, which may be the same or different, selected from R 5 is chloro, fluoro, methyl, difluoromethyl or trifluoromethyl; R 6 is cyclopropyl, phenyl, phenoxy, or pyridyl, where each cycloalkyl, phenyl, or pyridyl group is 7 and optionally substituted with one group represented by R 7 is chloro, fluoro, trifluoromethyl or trifluoromethoxy; and R 8 is chloro, fluoro or methyl.
[0063] In another set of embodiments, R 1 is hydrogen, cyano or acetyl; R2 is methoxy; R 3 is C1-C8 alkyl, C3-C7 alkynyl, C3-C4 cycloalkyl, C3-C4 cycloalkylC1-C2 alkyl, phenylC1-C3 alkyl, phenoxyC1-C3 alkyl, heteroaryl, heteroarylC1-C2 alkyl, heteroarylC1-C2 alkoxyiminoC1-C2 alkyl (wherein heteroaryl is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N and O), heterocyclyl, heterocyclylC1-C2 alkyl (wherein heterocyclyl is a 5- or 6-membered non-aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S), where the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are R 5 or one or two groups represented by 6 each optionally substituted with one group represented by 3 is a substituted heterocyclyl, these rings may contain carbonyl (C=O) or sulfonyl (S(O)2) groups; or R 3 is a 7-9 membered annulated ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N and O; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker; or R 3 is a 6-9 membered non-aromatic spirocyclic carbobicyclyl ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N and O; R 5 and optionally attached to the remainder of the molecule through a C1-C2 alkylene linker; R 4 is 3,5-difluorophenyl, 2,6-difluoropyridin-4-yl or isothiazol-4-yl; R 5 is halogen, C1-C3 alkyl, C1-C3 haloalkyl or C1-C3 haloalkoxy; R 6 is cyclopropyl, phenyl, phenoxy, or pyridyl, where each cycloalkyl, phenyl, or pyridyl group is 7 and R 8 is fluoro.
[0064] In a further set of embodiments, R 1 is hydrogen, cyano or acetyl; R 2 is hydrogen, methyl, chloro, bromo, fluoro, methoxy, ethoxy, isopropoxy, allyloxy, propargyloxy, difluoromethoxy, trifluoromethoxy or cyclopropoxy; R 3 are t-butyl, isopentyl, 2,2-dimethylpropyl, 1,5-dimethylhexyl, 1-methylcyclopropyl, 2,2-dimethylcyclobutyl, 1-trifluoromethylcyclopropylmethyl, (5-(trifluoromethyl)-2-pyridyl)cyclopropylmethyl, phenoxybenzyl, 4-trifluoromethoxyphenylethyl, 3,5-dichloro-4-pyridylmethyl, (3,5-dichloro-2-pyridyl)-2-ethoxyimino-ethyl, 5-cyclopropyltetrahydrofuran-3-yl, 3-methyltetrahydrofuran-3-yl methyl, 5-(trifluoromethyl)indan-1-yl, 6-(trifluoromethyl)indan-1-yl, pyrazolo[1,5-a]pyridin-7-ylmethyl, 2,3-dihydrobenzofuran-3-ylmethyl, 2,2-difluoro-1,3-benzodioxol-4-ylmethyl, 8-methyl-5-oxaspiro[3.5]nonan-8-yl, 7,7-dimethyl-2-oxabicyclo[3.2.0]heptan-6-yl, 2-oxabicyclo[3.2.0]heptan-7-yl or 4-oxaspiro[2.3]heptan-6-yl; R 4is 2,3-dihydroxypropyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclopropylmethyl, phenyl, 3-fluorophenyl, 3-chlorophenyl, 3-methylphenyl, 3-methoxyphenyl, 3,5-difluorophenyl, 3,5-dichlorophenyl, 3,5-dimethylphenyl, 3,5-dimethoxyphenyl, pyridin-4-yl, 2-fluoropyridin-4-yl, 2-chloropyridin-4-yl, 2,6-difluoropyridin-4-yl, 2,6-dichloropyridin-4-yl, pyridin-3-yl, 6-fluoropyridin-3-yl, 5-fluoropyridin-3-yl, 6-chloropyridin-3-yl, 5-chloropyridin-3-yl, isothiazol-4-yl, thiazol-2-yl, pyrimidin-5-yl or 1,3-benzodioxol-5-yl.
[0065] In a further set of embodiments, R 1 is hydrogen, cyano or acetyl; R 2 is methoxy; R 3 is t-butyl, isopentyl, 2,2-dimethylpropyl, 1-methylcyclopentyl, 1-methylcyclopropyl, 2,2-dimethylcyclobutyl or spiro[3.4]octan-3-yl; and R 4 is 3,5-difluorophenyl, 2,6-dichloropyridin-4-yl or isothiazol-4-yl.
[0066] In one set of embodiments, R 3 is R 5 or R 3 is an 8-membered spiro ring system, and R 4 is 3,5-difluorophenyl or 2,6-difluoro-4-pyridyl.
[0067] Preferably, the compound according to formula (I) is selected from compounds P-1 to P-50 shown in Table 3 (below).
[0068] Compounds of the invention can be formed as shown in the following schemes, where, unless otherwise specified, the definition of each variable is as defined above for compounds of formula (I).
[0069] The process for preparing the compounds of formula (I) according to the present invention is carried out by methods known to those skilled in the art and described in more detail below. For example, the compounds of formula (I) can be prepared by the method of formula (II): [ka] (In the formula, R 1 , R 2 and R 4 is as defined in formula (I). with a carboxylic acid of formula (III): [ka] (In the formula, R 3 is as defined in formula (I). can be prepared by reaction with amines under a variety of conditions known to those skilled in the art, some of which are outlined in Scheme 1. Scheme 1: [ka]
[0070] As shown in Scheme 1, R 1 , R 2 and R 4Compounds of formula (II), where X is as defined in formula (I), are activated to compounds of formula (IIa) by methods known to those skilled in the art, for example as described in Tetrahedron, 61(46), 10827-10852, 2005. For example, compounds of formula (IIa) where X is a halogen are formed by treatment of compounds of formula (II) with, for example, oxalyl chloride or thionyl chloride in the presence of a catalytic amount of DMF, in an inert solvent such as dichloromethane or THF, at temperatures between 25 and 170° C., preferably between 25 and 80° C. Optionally, R may be reacted with 1,2-dichloromethane or ... 3 Treatment of a compound of formula (IIa) with a compound of formula (III), where X is as defined in formula (I), gives a compound of formula (I). Alternatively, a compound of formula (I) can be prepared by condensing X into X in an inert solvent, for example pyridine or THF, optionally in the presence of a base, for example triethylamine, at a temperature between 50 and 180° C. 01 Or X 02 In addition, the acid of formula (II) can be activated by reaction with a coupling reagent such as phosphonic anhydride propane (T3P®) or O-(7-aza-1-benzotriazolyl)-N,N,N',N'-tetramethyluronium-hexafluorophosphate (HATU) to convert X0 to X, as described, for example, in Synthesis 2013, 45, 1569 and Journal Prakt.Chemie 1998, 340, 581. 03 and X 04 Subsequent reaction with an amine of formula (III) leads to a compound of formula (I).
[0071] R 1 , R 2 and R 4 is as defined in formula (I), [ka] The intermediate is R 4 , R 1 and R 2 is as described in formula (I), and R 9 is C1-C6 alkyl, formula (IV): [ka] For example, R 9 Compounds of formula (IV) where R is t-butyl on treatment with mineral acids or trifluoroacetic acid in an inert solvent such as methylene chloride or dioxane provide compounds of formula (II). Alternatively, R can be reacted with an aqueous alkaline earth metal base such as lithium hydroxide, sodium hydroxide or potassium hydroxide, optionally in the presence of a hydrating solvent such as THF, dioxane, acetone, etc. 9 Base hydrolysis of compounds of formula (IV) where is for example methyl, ethyl, isopropyl, etc., provides compounds of formula (II). Such reactions are known to those skilled in the art.
[0072] The compound of formula (IV) may be represented by formula (V): [ka] (In the formula, R 2 and R 9 is as described above, and Xa 1 is chlorine, bromine, iodine, arylsulfonate, alkylsulfonate or trifluoromethanesulfonic acid. and a compound of formula (VI): [ka] (In the formula, R 1 and R 4 is as defined in formula (I). The Buchwald-Hartwig reaction is a chemical reaction well known to those skilled in the art and used in organic chemistry for the synthesis of carbon-nitrogen bonds via palladium-catalyzed coupling reactions of amines with aryl and heteroaryl halides and sulfonates. Such reactions are reported, for example, in ACS catal., 2019, 3822-3830 and references cited therein. The reaction typically involves palladium catalysts such as Pd(OAc)2, Pd2(dba)3 and ligands such as diphenylphosphino binaphthyl (BINAP), and diphenylphosphino ferrocene (DPPF), and xantphos. More modern methods for the Buchwald-Hartwig coupling use palladium precatalysts such as BrettPhos Pd G3 (CAS[1470372-59-8]) or RuPhos Pd G3 (CAS[1445085-77-7]) to ensure efficient and rapid generation of the active catalytic species. The reaction requires the presence of a base such as alkaline earth metal alkoxides and hydroxides, for example potassium or sodium t-butoxide or potassium or sodium hydroxide, alkaline earth metal carbonates, for example sodium or cesium carbonate, and an organic base, for example 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU). These reactions are carried out in a variety of inert solvents, such as THF, water, toluene, dioxane, and DMF, and / or mixtures thereof, at temperatures between 20 and 170 °C (Buchwald, SLChem. Rev., 2016.116(19), 12564). This reaction is particularly useful for the synthesis of R 1 is hydrogen.
[0073] The chemistry involved in the synthesis of compounds of formula (I) is outlined in Scheme 2. Scheme 2: [ka]
[0074] One skilled in the art will recognize that the reaction order can be changed and compounds of formula (I) can also be synthesized as shown in Scheme 3. Scheme 3: [ka]
[0075] As shown in Scheme 3, esters of formula (V) can be hydrolyzed to compounds of formula (Va) by methods previously described and known to those skilled in the art. Acids of formula (Va) can be activated to compounds of formula (Vb), also using methods previously described, which upon treatment with compounds of formula (III) under conditions discussed in Scheme 2, afford compounds of formula (VII). Buchwald-Hartwig amination of compounds of formula (VII) with compounds of formula (VI) as previously described affords compounds of formula (I).
[0076] R 1 Compounds in which R is cyano, formyl, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 alkoxyC1-C6 alkylcarbonyl, C3-C6 cycloalkylcarbonyl, C1-C6 alkoxyC1-C3 alkoxycarbonyl, C1-C6 alkoxyoxalyl, C1-C6 alkoxycarbonylC1-C4 alkylC1-C6 alkoxycarbonyl, C2-C6 alkenyloxycarbonyl, C2-C6 alkynyloxycarbonyl, phenylcarbonyl, phenoxycarbonyl, heteroarylcarbonyl (wherein heteroaryl is a 5- or 6-membered aromatic monocyclic ring containing one or two heteroatoms individually selected from nitrogen, oxygen, and sulfur) can be prepared by methods well known to those skilled in the art. For example, 1Compounds in which is formyl, C1-C6 alkylcarbonyl, C1-C6 alkoxycarbonyl, C1-C6 haloalkylcarbonyl, C1-C6 alkoxyC1-C6 alkylcarbonyl, C3-C6 cycloalkylcarbonyl, C1-C6 alkoxyC1-C3 alkoxycarbonyl, C1-C6 alkoxyoxalyl, C1-C6 alkoxycarbonyl C1-C4 alkylC1-C6 alkoxycarbonyl, C2-C6 alkenyloxycarbonyl, C2-C6 alkynyloxycarbonyl, phenylcarbonyl, phenoxycarbonyl, heteroarylcarbonyl (wherein heteroaryl is a 5- or 6-membered aromatic monocyclic ring containing one or two heteroatoms individually selected from nitrogen, oxygen, and sulfur) are available as shown in Scheme 4. Scheme 4 [ka]
[0077] As shown in Scheme 4, a compound of formula (VIII), 1a is H, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl, C1-C6 alkoxyC1-C6 alkyl, C3-C6 cycloalkyl, C1-C6 alkoxyC1-C3 alkoxy, C1-C6 alkoxyoxalyl, C1-C6 alkoxycarbonylC1-C4 alkylC1-C6 alkoxycarbonyl, C2-C6 alkenyloxycarbonyl, C2-C6 alkynyloxy, C1-C6 alkylsulfanyl, phenyl, phenoxy, heteroaryl, which is a 5- or 6-membered aromatic monocyclic ring containing one or two heteroatoms individually selected from nitrogen, oxygen and sulfur), can be activated to compounds of formula (VIIIa) by the methods shown in Scheme 4 and already discussed in Scheme 1. Subsequent reaction of a compound of formula (VIIIa) or (VIII) with a compound of formula (Ia), optionally in the presence of a base, provides a compound of formula (Ib).
[0078] A compound of formula (I) 2 , R3 and R 4 is as defined for formula (I), and R 1 is cyano) (i.e., a compound of formula (Ic)) can be converted to a compound of formula (IX) (wherein Xa is cyano) in an inert solvent such as THF, dioxane, methylene chloride, and the like, by heating or with the aid of a base such as sodium hydride, butyllithium, or an organic base such as pyridine. 2 is available by reaction with a halogen, preferably bromo. This is shown in Scheme 5. Scheme 5 [ka]
[0079] Similar reactions have been reported in the literature, for example, Eur. J. Chem., 24(52), 13788-13791, 2018, Org. Lett., 19(14), 3835-3838, 2017, and Synthesis, 3077-3088, 2009.
[0080] A compound of formula (I) 1 , R 3 and R 4 is as described in formula (I), and R 3 is C1-C6 alkoxy, C1-C6 haloalkoxy, C3-C6 cycloalkyloxy, C3-C6 halocycloalkyloxy, C2-C6 alkenyloxy, C2-C6 haloalkenyloxy, C2-C6 alkynyloxy, C2-C6 haloalkynyloxy, C1-C6 cyanoalkyloxy, C1-C6 alkoxyC1-C3 alkoxy or C3-C6 cycloalkylC1-C2 alkoxy) (i.e., a compound of formula (Id)) is shown in Scheme 6. Scheme 6: [ka]
[0081] As shown in Scheme 6, a compound of formula (IX), 9 is C1-C6 alkyl, and Xa 1 is chlorine, bromine, iodine, arylsulfonate, alkylsulfonate or trifluoromethanesulfonic acid) can be obtained by treatment with, for example, sodium nitrite and a strong acid such as hydrochloric acid, sulfuric acid or HBF4 or with an organic nitrite such as, for example, t-butyl nitrite under anhydrous conditions, followed by the synthesis of a compound of formula R 10 -OH compound (wherein R 10 can be diazotized by methods known to those skilled in the art by treatment with a aryl group (C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C6 cyanoalkyl, C1-C6 alkoxyC1-C3 alkyl or C3-C6 cycloalkylC1-C2 alkyl) to give a compound of formula (Va). A compound of formula (Vc) is converted to a compound of formula (Iva) by a Buchwald-Hartwig coupling as described previously. A compound of formula (Iva) can be hydrolyzed to a compound of formula (IIb) by methods previously described and then coupled with a compound of formula (III) using methods similarly described in this application (Scheme 1) to give a compound of formula (Id).
[0082] It may be advantageous in some cases to prepare compounds of formula (Id) as shown in Scheme 7. Scheme 7: [ka]
[0083] One skilled in the art will recognize that the chemistry is similar to that shown in Scheme 6. Thus, diazotization of a compound of formula (X) and hydrolysis of the intermediate diazonium salt under acidic conditions affords Xa. 1 and R 9This gives a compound of formula (Vd), in which R is as previously described. Such reactions are described, for example, in Org. Synth. Coll. Vol. III, ECHorning Ed., Wiley, New York, 1956, Chapter I. As described in J. Org. Chem., 42, 1977, p. 2053, this reaction can also be carried out by reacting a diazonium salt with a copper salt. The compound of formula (Vd) is converted to a compound of formula (IVb) by the previously described Buchwald-Hartwig amination, and the ester (IVb) is hydrolyzed to a compound of formula (IIc) by the methods described above. The compound of formula (IIc) is then coupled with a compound of formula (III) by the methods described in Scheme 1 to give a compound of formula (Ie), in which R 1 , R 2 , R 3 and R 4 is as described in formula (I). Compounds of formula (Ie) can be prepared by reacting compounds of formula R in the presence of a base such as cesium carbonate, sodium carbonate or potassium carbonate and in an inert solvent such as DMF or acetonitrile. 10 -Xa 3 (wherein R 10 is C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C2-C6 haloalkynyl, C1-C6 cyanoalkyl, C1-C6 alkoxyC1-C3 alkyl or C3-C6 cycloalkylC1-C2 alkyl, and Xa 3 is a halogen) to give compounds of formula (Id). Such alkylation reactions are well known to those skilled in the art.
[0084] Compounds of formula (III), (VI) and (VIII) are commercially available or known in the literature. Compounds of formula (V) are also commercially available or known, for example methyl 6-bromopyrazine-2-carboxylate (CAS[40155-34-8]), methyl 3,6-dibromopyrazine-2-carboxylate (CAS[13301-04-7]), methyl 6-bromo-3-chloro-pyrazine-2-carboxylate (CAS[1256921-67-1]), methyl 6-bromo-3-iodo-pyrazine-2-carboxylate (CAS[1838713-31-7]), methyl 6-bromo-3-hydroxy ... The compounds are methyl 3-amino-6-bromo-pyrazine-2-carboxylate (CAS [21874-61-3]), methyl 3-amino-6-bromo-pyrazine-2-carboxylate (CAS [6966-01-4]), methyl 6-bromo-3-methoxy-pyrazine-2-carboxylate (CAS [259794-06-4]), ethyl 6-bromo-3-methyl-pyrazine-2-carboxylate (CAS [1823378-04-6]) and methyl 6-chloro-3-methyl-pyrazine-2-carboxylate (CAS [1166831-45-3]).
[0085] Surprisingly, it has now been found that the novel compounds of formula (I) have a very advantageous level of biological activity for protecting plants against diseases caused by fungi in fact.
[0086] The compounds of formula (I) can be used in the agricultural sector and related fields of use, for example as active ingredients for the control of plant pests or non-living materials, for the control of spoilage microorganisms or organisms potentially harmful to humans. The novel compounds are distinguished by their excellent activity at low application rates, their excellent tolerance by plants and their safety for the environment. They have highly useful curative, preventive and systemic properties and can be used to protect many cultivated plants. The compounds of formula (I) can be used to inhibit or eliminate pests occurring on plants or plant parts (fruits, flowers, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting these parts of later-growing plants from, for example, phytopathogenic microorganisms.
[0087] The present invention further relates to a method for controlling or preventing infestation of susceptible plants or plant propagation materials and / or harvested food crops by treating the plants or plant propagation materials and / or harvested food crops with a microorganism, comprising applying an effective amount of a compound of formula (I) to the plant, part thereof or its habitat.
[0088] The compounds of formula (I) may also be used as fungicides. The term "fungicide" as used herein means a compound that controls, modifies or prevents fungal growth. The term "fungicidally effective amount" means the amount of such a compound or combination of such compounds that can have an effect on fungal growth. A controlling or modifier effect includes any deviation from natural development such as killing, retardation, etc., and prevention includes the formation of a barrier or other defense in the plant to prevent infection by fungi.
[0089] The compounds of formula (I) can also be used as dressings to treat plant propagation material, such as seeds, such as fruits, tubers or grains, or plant cuttings (e.g., rice), for protection against fungal infections and phytopathogenic fungi occurring in the soil. The propagation material can be treated with a composition comprising a compound of formula (I) before planting. For example, seeds can be dressed before being sown.
[0090] The active ingredients according to the invention can also be applied to the grain (coating) by impregnating the seeds in a liquid formulation or coating the seeds with a solid formulation. The composition can also be applied to the planting site when the propagation material is planted, for example in the sowing furrow during sowing. The invention also relates to a method for treating such plant propagation material and to the plant propagation material thus treated.
[0091] Furthermore, the compounds according to the invention may be used for controlling fungi in related fields such as the protection of industrial materials, including wood and wood-based industrial products, food storage and hygiene.
[0092] In addition, the present invention may be used to protect non-living materials such as timber, wallboard and paint from fungal attack.
[0093] The compounds of formula (I) may be effective against, for example, fungi and fungal vectors associated with diseases, as well as phytopathogenic bacteria and viruses, such as, for example: Absidia corymbifera, Alternaria spp., Aphanomyces spp., Ascochyta spp., Aspergillus spp. including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terrus, Aureobasidium spp. including A. pullulans, Blastomyces dermatitidis, Blumeria graminis, Bremia lactucae, lactucae, B. dothidea, B. obtusa, Botryosphaeria spp. including B. cinerea, C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. tropicalis, Candida spp., Cephaloascus fragrans, Ceratocystis spp. spp., Cercospora spp. including C. arachidicola, Cercosporidium personatum, Cladosporium spp., Claviceps purpurea, Coccidioides immitis, Cochliobolus spp., Colletotrichum spp. including C. musae, Cryptococcus neoformans, Diaporthe spp, Didymella spp, Drechslera spp, Elsinoe spp, Erysiphe spp., including Epidermophyton spp., Erwinia amylovora, and E. cichoracearum; Fusarium spp. including Eutypa lata, F. culmorum, F. graminearum, F. langsethiae, F. moniliforme, F. oxysporum, F. proliferatum, F. subglutinans, and F. solani, Gaeumannomyces graminis, Gibberella fujikuroi, Gloeodes pomigena, Gloeosporium musarum, Glomerella cingulate, Guignardia bidwellii, Gymnosporangium juniperi-virginianae, Helminthosporium spp., Hemileia spp., Histoplasma spp. including H. capsulatum, Laetisaria fuciformis, Leptographium lindbergi, Leveillula taurica, Lophodermium seditiosum, Microdochium nivale, Microsporum spp. spp., Monilinia spp., Mucor spp., Mycosphaerella spp. including M. graminicola and M. pomi.), Oncobasidium theobromaeon, Ophiostoma piceae, Paracoccidioides spp., Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp., Peronosclerospora spp. including P. maydis, P. philippinensis and P. sorghi, Peronosclerospora spp., Phaeosphaeria nodorum, Phakopsora pachyrhizi, Phellinus igniarus, Phialophora spp., Phoma spp., Phomopsis viticola, Phytophthora spp. including P. infestans, Plasmopara spp. including P. halstedii, P. viticola, Pleospora spp., Podosphaera spp. including P. leucotricha, Polymyxa graminis, graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp., Pseudoperonospora spp. including P. cubensis, P. humuli.), Puccinia spp. including P. hordei, P. recondita, P. striiformis, P. triticina, Pyrenopeziza spp., Pyrenophora spp., Pyricularia spp. including P. oryzae, Pythium spp. including P. ultimum, Ramularia spp., Rhizoctonia spp., Rhizomucor pusillus pusillus, Rhizopus arrhizus, Rhynchosporium spp., Scedosporium spp. including S. apiospermum and S. prolificans, Schizothyrium pomi, . Sclerotinia spp., Sclerotium spp., Septoria spp. including S. nodorum, S. tritici, Sphaerotheca macularis, Sphaerotheca fusca (Sphaerotheca fuliginea), Sporothorix spp., Stagonospora nodorum, Stemphylium spp., Stereum hirsutum, Thanatephorus cucumeris, Thielaviopsis basicola basicola, Tilletia spp., Trichoderma spp. including T. harzianum, T. pseudokoningii, and T. viride, Trichophyton spp., Typhula spp., Uncinula necator, Urocystis spp., Ustilago spp., Venturia spp. including V. inaequalis, Verticillium spp. and Xanthomonas spp.
[0094] Within the scope of the present invention, the target crops and / or useful plants to be protected are typically berry plants, such as blackberries, blueberries, cranberries, raspberries and strawberries; cereals, such as barley, maize (corn), millet, oats, rice, rye, sorghum, triticale and wheat; fibre plants, such as cotton, flax, hemp, jute and sisal; agricultural crops, such as sugar and fodder beet, coffee, hops, mustard, oilseed rape (canola), poppy, sugarcane, sunflower, tea and tobacco; fruit trees, such as apple, apricot, avocado, banana, cherry, citrus, nectarine, peach, pear and plum; and arable plants, such as bermuda grass, strawberry bush, bentgrass, centipede grass, fescue, ryegrass, lawn grass and wild grass. herbs such as basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes such as beans, lentils, peas and soybeans; nuts such as almonds, cashews, groundnuts, hazelnuts, peanuts, pecans, pistachios and walnuts; palms such as oil palm; ornamental plants such as flowers, shrubs and trees; other trees such as cocoa, coconut, olive and rubber; vegetables such as asparagus, eggplant, broccoli, cabbage, carrots, cucumber, garlic, lettuce, squash, melon, okra, onion, pepper, potato, pumpkin, rhubarb, spinach and tomato; and perennial and annual crops such as vines, for example grapes.
[0095] The term "useful plants" should also be understood to include useful plants in which resistance to herbicides such as bromoxynil or to a class of herbicides (e.g. HPPD inhibitors, ALS inhibitors such as primisulfuron, prosulfuron and trifloxysulfuron, EPSPS (5-enol-pyroyl-shikimate-3-phosphate-synthase) inhibitors, GS (glutamine synthetase) inhibitors or PPO (protoporphyrinogen-oxidase) inhibitors, etc.) has been imparted by conventional breeding or genetic engineering methods. An example of a crop in which resistance to imidazolinones, e.g. imazamox, has been imparted by conventional breeding methods (mutagenesis) is Clearfield® summer rapeseed (canola). Examples of crops that have been rendered resistant to herbicides or classes of herbicides by genetic engineering methods include glyphosate- and glufosinate-tolerant corn varieties commercially available under the trade names RoundupReady®, Herculex I®, and LibertyLink®.
[0096] The term "useful plants" should also be understood to include useful plants that have been transformed using recombinant DNA techniques with the ability to synthesize one or more selectively acting toxins, such as those known to be derived from toxin-producing bacteria, particularly those from the genus Bacillus.
[0097] Examples of such plants are YieldGard® (corn varieties expressing CryI(A)(b) toxin); YieldGard Rootworm® (corn varieties expressing CryIIIB(b1) toxin); YieldGard Plus® (corn varieties expressing CryI(A)(b) and CryIIIB(b1) toxins); Starlink® (corn varieties expressing Cry9(c) toxin); Herculex I® (corn varieties expressing CryIF(a2) toxin and the enzyme phosphinothricin N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton varieties expressing CryI(A)(c) toxin); Bollgard I® (cotton varieties expressing CryI(A)(c) toxin); Bollgard II® (a cotton variety expressing CryI(A)(c) and CryII(A)(b) toxins); VIPCOT® (a cotton variety expressing a VIP toxin); NewLeaf® (a potato variety expressing a CryIII(IA) toxin); NatureGard® Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait), Agrisure® RW (corn rootworm trait), and Protecta®.
[0098] The term "crop plant" should also be understood to include crop plants that have been transformed, using recombinant DNA techniques, so as to have the ability to synthesize one or more selectively acting toxins, such as those known to be derived from toxin-producing bacteria, particularly bacteria of the genus Bacillus.
[0099] Toxins that may be expressed by such transformed plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as δ-endotoxins, e.g. Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1, Vip2, Vip3 or Vip3A; or insecticidal proteins from Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus, for example. spp.); toxins produced by animals such as scorpion toxins, spider toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi such as Streptomycete toxins, plant lectins such as pea lectin, barley lectin or snowdrop lectin; agglutinins; proteinase inhibitors such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors; ricin, Ribosome-inactivating proteins (RIPs) such as maize-RIP, abrin, rufin, saporin or bryodin; steroid metabolic enzymes such as 3-hydroxysteroid oxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidase, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers such as sodium or calcium blockers, juvenile hormone esterase, diuretic hormone receptor, stilbene synthase, bibenzyl synthase, chitinase and glucanase.
[0100] In the context of the present invention, delta-endotoxins, such as Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or trophic insecticidal proteins (Vip), such as Vip1, Vip2, Vip3 or Vip3A, are to be understood as being particularly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are recombinantly produced by new combinations of different domains of these proteins (see, for example, WO 02 / 15701). Truncated toxins, such as, for example, truncated Cry1Ab, are known. In the case of modified toxins, one or more amino acids of the natural toxin are replaced. In such amino acid substitutions, preferably a non-naturally occurring protease recognition sequence is inserted into the toxin, for example in the case of Cry3A055 a cathepsin-G recognition sequence is inserted into the Cry3A toxin (see WO 03 / 018810).
[0101] Further examples of such toxins or transformed plants capable of synthesizing such toxins are disclosed, for example, in EP-A-0 374 753, WO-A-93 / 07278, WO-A-95 / 34656, EP-A-0 427 529, EP-A-451 878 and WO-A-03 / 052073. The preparation processes of such transformed plants are generally known to the skilled artisan and are described, for example, in the abovementioned publications. CryI-type deoxyribonucleic acids and their preparation are known, for example, from WO-A-95 / 34656, EP-A-0 367 474, EP-A-0 401 979 and WO-A-90 / 13651.
[0102] The toxins contained in the transformed plants confer resistance to harmful insects on the plants, which can be of any taxonomic group of insects, but are particularly commonly found among beetles (Coleoptera), two-winged insects (Diptera), and butterflies (Lepidoptera).
[0103] Transgenic plants containing one or more genes encoding insecticide resistance and expressing one or more toxins are known, and some are commercially available. Examples of such plants include YieldGard® (a corn variety expressing Cry1Ab toxin); YieldGard Rootworm® (a corn variety expressing Cry3Bb1 toxin); YieldGard Plus® (a corn variety expressing Cry1Ab and Cry3Bb1 toxins); Starlink® (a corn variety expressing Cry9C toxin); Herculex I® (a corn variety expressing Cry1Fa2 toxin and the enzyme phosphinothricin N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (a cotton variety expressing Cry1Ac toxin); Bollgard I® (a cotton variety expressing Cry1Ac toxin); Bollgard II® (a cotton variety expressing Cry1Ac and Cry2Ab toxins); VipCot® (a cotton variety expressing Vip3A and Cry1Ab toxins); NewLeaf® (a potato variety expressing Cry3A toxin); NatureGard®, Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait), and Protecta®.
[0104] Further examples of such transformed crops are as follows: 1. Bt11 maize, registration number C / FR / 96 / 05 / 10, manufactured by Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France. A genetically engineered maize (Zea mays) that is resistant to the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1Ab toxin. Bt11 maize also achieves tolerance to the herbicide glufosinate ammonium by transgenic expression of the enzyme PAT.
[0105] 2. Bt176 maize, registration number C / FR / 96 / 05 / 10, from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France. A genetically engineered maize (Zea mays) that is resistant to the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of the Cry1Ab toxin. Bt176 maize also achieves tolerance to the herbicide glufosinate ammonium by transgenic expression of the enzyme PAT.
[0106] 3. MIR604 maize, registration number C / FR / 96 / 05 / 10, from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France. Maize conferred insect resistance by transgenic expression of a modified Cry3A toxin. The toxin is Cry3A055 modified by the insertion of a cathepsin-G-protease recognition sequence. The preparation of such transformed maize plants is described in WO 03 / 018810.
[0107] 4. MON863 maize, registration number C / DE / 02 / 9, from Monsanto Europe SA 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium. MON863 expresses the Cry3Bb1 toxin and confers resistance to certain coleopteran insects.
[0108] 5. IPC531 Cotton made by Monsanto Europe SA 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / ES / 96 / 02.
[0109] 6. 1507 corn from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1160 Brussels, Belgium, registration number C / NL / 00 / 10. Maize genetically engineered for expression of the protein Cry1F to achieve resistance to certain lepidopteran insects and for expression of the PAT protein to achieve resistance to the herbicide glufosinate ammonium.
[0110] 7. NK603 x MON810 maize, registration number C / GB / 02 / M3 / 03, from Monsanto Europe SA 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium. It consists of a conventional hybrid maize variety by crossing the genetically engineered varieties NK603 and MON810. NK603 x MON810 maize transgenic expresses the protein CP4 EPSPS from the strain CP4 of Agrobacterium sp., which confers resistance to the herbicide Roundup® (containing glyphosate), and the Cry1Ab toxin from Bacillus thuringiensis subsp. kurstaki, which confers resistance to certain Lepidoptera, including the European corn borer.
[0111] Also, Absidia corymbifera, Alternaria spp., Aphanomyces spp., Ascochyta spp., Aspergillus spp. including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terrus, Aureobasidium spp. including A. pullulans, Blastomyces dermatitidis, Blumeria graminis, Bremia lactucae, lactucae, B. dothidea, B. obtusa, Botryosphaeria spp. including B. cinerea, C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. tropicalis, Candida spp., Cephaloascus fragrans, Ceratocystis spp. spp., Cercospora spp. including C. arachidicola, Cercosporidium personatum, Cladosporium spp., Claviceps purpurea, Coccidioides immitis, Cochliobolus spp., C. musae, C.Colletotrichum spp. including Colletotrichum spp., Cryptococcus neoformans, Diaporthe spp., Didymella spp., Drechslera spp., Elsinoe spp., Epidermophyton spp., Erwinia amylovora, Erysiphe spp. including E. cichoracearum, Eutypa Fusarium spp. including F. lata, F. culmorum, F. graminearum, F. langsethiae, F. moniliforme, F. oxysporum, F. proliferatum, F. subglutinans, and F. solani, Gaeumannomyces graminis, Gibberella fujikuroi, Gloeodes pomigena, Gloeosporium musarum, Glomerella cingulate, Guignardia bidwellii, Gymnosporangium juniperi-virginianae, Helminthosporium spp., Hemileia spp., Histoplasma spp. including H. capsulatum.), Laetisaria fuciformis, Leptographium lindbergi, Leveillula taurica, Lophodermium seditiosum, Microdochium nivale, Microsporum spp., Monilinia spp., Mucor spp., M. graminicola, Mycosphaerella spp. including M. pomi, Oncobasidium theobromaeon, Ophiostoma piceae, Paracoccidioides spp., Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp., Peronosclerospora spp. including P. maydis, P. philippinensis and P. sorghi, Peronosclerospora spp., Phaeosphaeria nodorum, Phakopsora pachyrhizi, Phellinus ignialus igniarus, Phialophora spp., Phoma spp., Phytophthora spp. including Phomopsis viticola, P. infestans, Plasmopara spp. including P. halstedii, P. viticola.), Pleospora spp., Podosphaera spp. including P. leucotricha, Polymyxa graminis, Polymyxa betae, Pseudocercosporella herpotrichoides, Pseudomonas spp., Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopezizatrakeiphila spp. Puccinia spp., including P. tracheiphila, P. hordei, P. recondita, P. striiformis, P. triticina, Pyrenopeziza spp., Pyrenophora spp., Pyricularia spp., including P. oryzae, Pythium spp., including P. ultimum, Ramularia spp., Rhizoctonia spp., Rhizomucor pusillus, Rhizopus arizus, arrhizus, Rhynchosporium spp., Scedosporium spp. including S. apiospermum and S. prolificans, Schizothyrium pomi, Sclerotinia spp., Sclerotium spp., S. nodorum, S. tritici, S.Septoria spp. (including Septoria tritici), Sphaerotheca macularis, Sphaerotheca fusca (Sphaerotheca fuliginea), Sporothorix spp., Stagonospora nodorum, Stemphylium spp., Stereum hirsutum, Thanatephorus cucumeris, Thielaviopsis basicola, Tilletia spp. spp., Trichoderma spp. including T. harzianum, T. pseudokoningii, T. viride, Trichophyton spp., Typhula spp., Uncinula necator, Urocystis spp., Ustilago spp., Venturia spp. including V. inaequalis.), Verticillium spp and Xanthomonas spp, in particular Zymoseptoria tritici, Puccinia recondita, Puccinia striiformis, Erysiphe graminis, Uncinula necator, Sphaerotheca fuliginea, Leveillula taurica, Phakopsora pachyrhizi, Pyricularia oryzae, Alternaria solani, Alternaria alternata,. Mycosphaerella fijiensis, Colletotrichum lagenarium, Didymella bryoniae, Ascochyta pisii, Verticillium dahliae, Pyrenophora teres, Cercospora beticola, Ramularia collo-cygni, Botrytis cinerea, Sclerotinia sclerotiorum, Monilinia laxa, Monographaella nivalis and Venturia No cross-resistance has been observed between any of the fungicidal solutions used to control phytopathogenic fungi, such as Pseudomonas inaequalis, and the compounds of formula (I) (including any one of the compounds set out in Table 3 (below)).
[0112] Indeed, fungicide-resistant strains of any of the above mentioned species have been reported in the scientific literature, where the strains are resistant to one or more fungicides according to at least one of the following fungicide mode of action classifications: quinone external inhibitors (QoI), quinone internal inhibitors (QiI), succinate dehydrogenase inhibitors (SDHI) and sterol demethylase inhibitors (DMI). Such fungicide-resistant strains may include: Mutations in the mitochondrial cytochrome b gene that confer resistance to Qo inhibitors, such as G143A, F129L or G137R, see e.g. Gisi et al., Pest Manag Sci 56, 833-841, (2000); Lucas, Pestic Outlook 14(6), 268-70 (2003); Fraaije et al., Phytopathol 95(8), 933-41 (2005); Sierotzki et al., Pest Manag Sci 63(3), 225-233 (2007); Semar et al., Journal of Plant Diseases and Protection(3), 117-119 (2007); and Pasche et al., Crop Protection 27(3-5), 427-435 (2008). A mutation in the mitochondrial cytochrome b gene that confers resistance to Qi inhibitors: G37A / C / D / S / V. See, e.g., Meunier et al., Pest Manag Sci 2019;75:2107-2114. Mutations in the genes encoding the SdhB, C, and D subunits that confer resistance to SDHI inhibitors in the following major pathogens: Botrytis cinerea: B-P225H / L / T / Y / F, B-N230I, B-H272L / Y / R, C-P80H / L, C-N87S; Alternaria solani: B-H278R / Y, C-H134R / Q, D-D123E, D-H133R and C-H134R; ○Zymoseptoria tritici:sdhB:N225T, N225I, R265P, T268I, T268A.In sdhC:T79N, T79I, W80S, W80A, A84F, N86S, N86A, P127A, R151M / S / T / G, R151S, R151T, H152R / Y, V166M, T168R.In sdhD:I50F, M114V, D129G, T20P+K186R; Pyrenophora teres: In sdhB: S66P, N235I, H277Y. In sdhC: K49E, R64K, N75S, G79R, H134R, S135R. In sdhD: D124E, H134R, G138V, D145G; Ramularia collo-cygni: In sdhB: N224T, T267I. In sdhC: N87S, G91R, H146R / L, G171D, H153R; Phakopsora pachyrhizi: C-I86F; ○Sclerotinia sclerotiorum:In sdhB:H273Y.In sdhC:G91R, H146R.In sdhD:T108K, H132R, G150R.
[0113] The main sources of information are www.frac.info, Sierotzki and Scalliet Phytopathology (2013) 103(9):880-887 and Simoes et al., J Plant Dis Prot (2018) 125:21-2. Mutations or combinations of mutations in the CYP51 gene that confer resistance to DMI inhibitors, where the mutations are: L50S, D134G, V136A / C, Y137F, S188N, A379G, I381V, deletions 459-460, Y461H / S, N513K, S524T. Main sources of information are www.frac.info, Cools et al., Plant Pathol(2013)62:36-42 and Schmitz HK et al., Pest Manag Sci(2014)70:378-388.
[0114] Therefore, in a preferred embodiment, a compound of formula (I) (including any one of the compounds set out in Table 3 (below)) or a fungicidal composition according to the invention comprising a compound of formula (I) is used for the control of fungal strains which are resistant to one or more fungicides in any of the following fungicidal MoA classifications: quinone external inhibitors (QoIs), quinone internal inhibitors (QiIs), succinate dehydrogenase inhibitors (SDHIs) and sterol demethylation inhibitors (DMIs).
[0115] As used herein, the term "habitat" refers to the field in which the plant is growing or in which the seeds of the cultivated plant have been sown or in which the seeds will be sown in the soil. It includes the soil, the seeds and seedlings, as well as established vegetation.
[0116] The term "plant" refers to all physical parts of a plant, including seeds, seedlings, seedlings, roots, tubers, stems, stalks, foliage and fruits.
[0117] The term "plant propagation material" is understood to refer to reproductive parts of plants, such as seeds, which can be used for their propagation, and vegetative bodies, such as cuttings or tubers, for example potatoes. For example, seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes and plant parts may be mentioned. Also mentioned are sprouted plants and shoots that are to be transplanted after germination or emergence from the soil. These shoots may be protected by a complete or partial treatment by immersion before transplantation. Preferably, "plant propagation material" is understood to refer to seeds.
[0118] The pesticides referred to herein using their common names are known, for example, from “The Pesticide Manual”, 15th Ed., British Crop Protection Council 2009.
[0119] The compounds of formula (I) can be used in their original form or preferably together with the auxiliaries that are conveniently employed in the field of formulation technology.For this purpose, they can be conveniently formulated in a known manner into emulsifiable concentrates, coating pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granules and capsules, for example, in polymeric materials.The application method, such as spraying, misting, dusting, scattering, coating or pouring, as well as the type of composition, is selected according to the intended purpose and the situation at hand.The composition can contain further auxiliaries, such as stabilizers, defoamers, viscosity regulators, binders or adhesives and fertilizers, sources of trace elements or other compounds for obtaining special effects.
[0120] For example, suitable carriers and adjuvants for use in agriculture may be solid or liquid and are substances useful in formulation technology, such as natural or regenerated mineral substances, solvents, dispersants, wetting agents, adhesives, thickeners, binders or fertilizers. Such carriers are described, for example, in WO 97 / 33890.
[0121] The compounds of formula (I) are usually used in the form of compositions and can be applied to the crop area or plants to be treated simultaneously or sequentially with further compounds. These further compounds can be, for example, fertilizers or trace element donors or other preparations that influence plant growth. They can be selective or non-selective herbicides and insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of the preparations, if necessary with further carriers, surfactants or application-promoting adjuvants customarily used in the field of formulations.
[0122] The compounds of formula (I) may be used in the form of a (fungicidal) composition for the control or protection against phytopathogenic microorganisms, comprising as active ingredient at least one compound of formula (I) or in the form of at least one preferred individual compound as defined above, in free form or in the form of an agrochemically usable salt, and at least one of the adjuvants described above.
[0123] The present invention provides a composition, preferably a fungicidal composition, comprising at least one compound of formula (I), an agriculturally acceptable carrier and optionally an adjuvant. An agriculturally acceptable carrier is, for example, a carrier suitable for agricultural use. Agricultural carriers are well known in the art. Preferably, the composition may comprise, in addition to the compound of formula (I), at least one or more pesticidal active compounds, for example additional fungicidal active ingredients.
[0124] The compound of formula (I) may be the sole active ingredient in the composition or, where appropriate, may be mixed with one or more additional active ingredients, such as pesticides, fungicides, synergists, herbicides or plant growth regulators, which may in some cases result in unexpected synergistic activity.
[0125] Examples of suitable additional active ingredients are the following: acyl amino acid fungicides, aliphatic nitrogen fungicides, amide fungicides, anilide fungicides, antibiotic fungicides, aromatic fungicides, arsenic fungicides, aryl phenyl ketone fungicides, benzamide fungicides, benzanilide fungicides, benzimidazole fungicides, benzothiazole fungicides, botanical fungicides, fungicides, bridged diphenyl fungicides, carbamate fungicides, carbanilate fungicides, conazole fungicides, copper fungicides, dicarboximide fungicides, dinitrophenol fungicides, dithiocarbamate fungicides, dithiolane fungicides, furamide fungicides, furanilide fungicides, hydrazide fungicides, imidazole fungicides, mercury fungicides, Morpholine fungicides and fungicides, organophosphate fungicides and fungicides, organotin fungicides and fungicides, oxathiin fungicides and fungicides, oxazole fungicides and fungicides, phenylsulfamide fungicides and fungicides, polysulfide fungicides and fungicides, pyrazole fungicides and fungicides, pyridine fungicides and fungicides, pyrimidine fungicides and fungicides, pyrrole fungicides and fungicides, quaternary ammonium fungicides and fungicides, quinoline fungicides and fungicides, quinone fungicides and fungicides, quinoxaline fungicides These include fungicides, strobilurin fungicides, sulfonanilide fungicides, thiadiazole fungicides, thiazole fungicides, thiazolidine fungicides, thiocarbamate fungicides, thiophene fungicides, triazine fungicides, triazole fungicides, triazolopyrimidine fungicides, urea fungicides, valinamide fungicides and zinc fungicides.
[0126] Examples of suitable additional active ingredients also include: petroleum, 1,1-bis(4-chlorophenyl)-2-ethoxyethanol, 2,4-dichlorophenylbenzenesulfonate, 2-fluoro-N-methyl-N-1-cinnamaldehyde, 4-chlorophenyl phenylsulfone, acetoprole, aldoxicarb, amidithione, amidothioate, amiton, amiton hydrogen oxalate, amitraz, aramite, arsenic trioxide, azobenzene, azotoate, benomyl, benoxafos, benzyl benzoate, bixafen, brofenvalerate, bromobenzo ... Mocyclene, Bromophos, Bromopropylate, Buprofezin, Butocarboxim, Butoxycarboxim, Butylpyridaben, Calcium polysulfate, Camphechlor, Carbanolate, Carbophenothione, Cymiazole, Tinomethionate, Chlorbeneside, Chlordimeform, Chlordimeform hydrochloride, Chlorphenetole, Chlorphenson, Chlorphenesulfide, Chlorobenzilate, Chlormebuform, Chlormethiuron, Chloropropylate, Chlorthiophos, Cinerin I, Cinerin II, Cinerins, Closantel, Kumafo s, crotamiton, crotoxyphos, kufraeb, cyanthoate, DCPM, DDT, demefion, demefion-O, demefion-S, demeton-methyl, demeton-O, demeton-O-methyl, demeton-S, demeton-S-methyl, demeton-S-methyl sulfone, dichlofluanid, dichlorvos, dicrifos, dienochlor, dimefox, ginex, ginex-diclexin, dinocap-4, dinocap-6, dinokton, dinopenton, dinosulfone, dinotervone, dioxathion, diphenylsulfone, disulfiram, DNOC, Dofenapine, doramectin, endothion, epirimectin, ethoeate methyl, etrimphos, fenazaflor, fenbutatin oxide, fenothiocarb, fenpyrad, fenpyroximate, fenpyrazamine, fenson, fentrifanil, flubenzimine, flucycloxuron, fluenethyl, fluorbenside, FMC1137, formetanate, formetanate hydrochloride, formoparanate, gamma-HCH, gliodin, halfenprox, hexadecylcyclopropanecarboxylate, isocarbophos, jasmolin I,Jasmolin II, Jodofenphos, Lindane, Malonoben, Mecarbam, Mefosfolan, Mesulfen, Methacrifos, Methyl bromide, Metolcarb, Mexacarbate, Milbemycin oxime, Mipafox, Monocrotophos, Morphothion, Moxidectin, Naled, 4-Chloro-2-(2-chloro-2-methyl-propyl)-5-[(6-iodo-3-pyridyl)methoxy]pyridazin-3-one, Nifluridide, Nikkomycin, Nitrilacarb, Nitrilacarb 1:1 zinc chloride complex, Omethoate, Oxydeprophos, Oxydisulfoton, pp'-DDT, parathion, permethrin, fencaptone, phosalone, phospholane, phosphamidon, polychloroterpene, polynactin, proclonol, promacyl, propoxur, prothidathion, protoate, pyrethrin I, pyrethrin II, pyrethrins, pyridaphenthion, pyrimitate, quinalphos, quinthiophos, R-1492, phosglycine, rotenone, shladan, cebufos, selamectin, sofamid, SSI-121, sulfiram, sulfuramide, sulfotep, sulfur, diflovidazin, tau-fluvalinate, TEPP, te 1,2-Dimethylphenylacetate, ... Larose, fenthion, pyridin-4-amine, strychnine, 1-hydroxy-1H-pyridine-2-thione, 4-(quinoxalin-2-ylamino)benzenesulfonamide, 8-hydroxyquinoline sulfate, bronopol, copper hydroxide, cresol, dipyrithione, doditin, phenaminosulf, formaldehyde, hydralgafen, kasugamycin, kasugamycin hydrochloride hydrate, nickel bis(dimethyldithiocarbamate), nitrapyrin, octhilinone, oxolinic acid, oxytetracycline, potassium hydroxyquinoline sulfate,Probenazole, Streptomycin, Streptomycin sesquisulfate, Tecloftalam, Thiomersal, Adoxophyes orana GV, Agrobacterium radiobacter, Amblyseius spp., Anagrapha falcifera NPV, Anagrus atomus, Aphelinus abdominalis, Aphidius colemani, Aphidoletes aphidimyza, Autographa californica NPV, Bacillus sphaericus Neide, Beauveria brongniartii, Chrysoperla carnea, Cryptolaemus montrouzieri, Cydia pomonella GV, Dacnusa sibirica, Diglyphus isaea, Encarsia formosa, Eretmocerus eremicus, Heterorhabditis bacteriophora and H. megidis, Hippodamia convergens, Leptomastix dactylopii, Macrolophus caliginosus caliginosus, Mamestra brassicae NPV, Metaphycus helvolus, Metarhizium anisopliae var. acridum, Metarhizium anisopliae var. anisopliae,Neodiprion sertifer NPV and N. lecontei NPV, Orius spp., Paecilomyces fumosoroseus, Phytoseiulus persimilis, Steinernema bibionis, Steinernema carpocapsae, Steinernema feltiae, Steinernema glaseri, Steinernema riobrave, Steinernema riobravis, Steinernema scapterisci, Steinernema spp., Trichogramma spp., Typhlodromus occidentalis occidentalis), Verticillium lecanii, apholate, bisadil, busulfan, dimatif, hemel, hempa, metepa, methiotepa, methyl apholate, molzide, penfluron, tepa, thiohempa, thiotepa, tretamine, uredepa, (E)-dec-5-en-1-yl acetate + (E)-dec-5-en-1-ol, (E)-tridec-4-en-1-yl acetate, (E)-6-methylhept-2-en-4-ol, (E,Z)-tetradec-4,10-dien-1-yl acetate, (Z)-dodec-7-en-1-yl acetate, (Z)-hexadec-11-enal, ( Z)-Hexadec-11-en-1-yl acetate, (Z)-hexadec-13-en-11-yn-1-yl acetate, (Z)-icos-13-en-10-one, (Z)-tetradec-7-en-1-al, (Z)-tetradec-9-en-1-ol, (Z)-tetradec-9-en-1-yl acetate, (7E,9Z)-dodeca-7,9-dien-1-yl acetate, (9Z,11E)-tetradec-9,11-dien-1-yl acetate, (9Z,12E)-tetradec-9,12-dien-1-yl acetate, 14-methyloctadec-1-ene,4-Methylnonan-5-ol + 4-Methylnonan-5-one, α-Murtistriatin, Brevicomin, Codrelle, Codremon, Querle, Disparlure, Dodec-8-en-1-yl acetate, Dodec-9-en-1-yl acetate, Dodec-8,10-dien-1-yl acetate, Dominicalure, Ethyl 4-methyloctanoate, Eugenol, Frontalin, Grandolure, Grandolure I, Grandolure II, Grandolure III, Grandolure IV, Hexalure, Ipsdienol, Ipsenol, Japonilure, Lineatin, Litrure, Lupulure, Medulure, Megatomoic acid, Methyl eugenol, Muscalure, Octadeca-2,13-dien-1-yl acetate, Octadeca-3,13-dien-1-yl acetate, Olphular, Orictalure, Ostramon, Siglua, Soldigin, Sulcatol, Tetradec-11-en-1-yl acetate, Trimedulure, Trimedulure A, Trimedulure B1, Trimedulure B2, Trimedulure C, Trunc-call, 2-(Octylthio)ethanol, Butapyronoxyl, Butoxy(polypropylene) glycol), dibutyl adipate, dibutyl phthalate, dibutyl succinate, diethyl toluamide, dimethylcarbate, dimethyl phthalate, ethyl hexanediol, hexamide, methoquin-butyl, methyl neodecaneamide, oxamate, picaridin, 1-dichloro-1-nitroethane, 1,1-dichloro-2,2-bis(4-ethylphenyl)ethane, 1,2-dichloropropane + 1,3-dichloropropene, 1-bromo-2-chloroethane, 2,2,2-trichloro-1-(3,4-dichlorophenyl)ethyl acetate, 2,2-dichlorobi Nyl 2-ethylsulfinylethyl methyl phosphate, 2-(1,3-dithiolan-2-yl)phenyl dimethyl carbamate, 2-(2-butoxyethoxy)ethyl thiocyanate, 2-(4,5-dimethyl-1,3-dioxolan-2-yl)phenyl methyl carbamate, 2-(4-chloro-3,5-xylyloxy)ethanol, 2-chlorovinyl diethyl phosphate, 2-imidazolidone, 2-isovalerylindan-1,3-dione, 2-methyl(prop-2-ynyl)aminophenyl methyl carbamate, 2-thiocyanatoethyl laurate,3-Bromo-1-chloroprop-1-ene, 3-methyl-1-phenylpyrazol-5-yl dimethyl carbamate, 4-methyl(prop-2-ynyl)amino-3,5-xylylmethylcarbamate, 5,5-dimethyl-3-oxocyclohex-1-enyl dimethyl carbamate, acetione, acrylonitrile, aldrin, allosamidin, alixycarb, α-ecdysone, aluminum phosphide, aminocarb, anabasine, atidathion, azamethiphos, Bacillus thuringiensis thuringiensis) delta endotoxin, barium hexafluorosilicate, barium polysulfide, bartholin, Bayer 22 / 190, Bayer 22408, beta-cyfluthrin, beta-cypermethrin, bioethanomethrin, biopermethrin, bis(2-chloroethyl)ether, sodium borate, bromfenvinphos, bromo-DDT, bufencarb, butacarb, butathiophos, butonate, calcium arsenate, calcium cyanide, carbon disulfide, carbon tetrachloride, cartap hydrochloride, sebazine, chlorbicyclen, chlordane, chlordecone, chloroform, chloropicrin, chlorphoxim, chlor Prazophos, cis-resmethrin, cismethrin, clocithrin, copper acetoarsenite, copper arsenate, copper oleate, cumitoate, cryolite, CS708, cyanofenphos, cyanophos, ciclethrin, cithioate, d-tetramethrin, DAEP, dazomet, decarbofuran, diamidaphos, dicapton, dichlorophenthion, dicresyl, dicyclanil, dieldrin, diethyl 5-methylpyrazol-3-yl phosphate, dilol, dimefluthrin, dimethane, dimethrin, dimethylvinphos, dimethylan, dinoprop, dinosam, dinoseb, diofenolan, dioxabenzophos, dicyclophos, DSP, ecdysterone, EI 1642, EMPC, EPBP, ethaphos, ethiofencarb, ethyl formate, ethylene dibromide, dichloroethane, ethylene oxide, EXD, fenchlorphos, fenetacarb, fenitrothion, fenoxacrim, fenpyritrin, fensulfothion, fenthion-ethyl, flucofuron, fosmetiran, fospirate, fostietan, furathiocarb, fretrin, guazatine, guazatine acetate,Sodium tetrathiocarboxylate, Halfenprox, HCH, HEOD, Heptachlor, Heterofos, HHDN, Hydrogen cyanide, Hikincarb, IPSP, Isazophos, Isobenzan, Isodrin, Isofenphos, Isorane, Isoprothiolane, Isoxathion, Juvenile hormone I, Juvenile hormone II, Juvenile hormone III, Kereban, Kinoprene, Lead arsenate, Leptophos, Lilimphos, Ritidathion, m-Cumenylmethylcarbamate, Magnesium phosphide, Magidox, Mecarfone, Menazone, Mercurous chloride, Mesulfenphos, Metam, Metam -Potassium, metham-sodium, methanesulfonyl fluoride, methoclotophos, methoprene, methotrin, methoxychlor, methyl isothiocyanate, methyl chloroform, methylene chloride, methoxadiazone, mirex, naphthalophos, naphthalene, NC-170, nicotine, nicotine sulfate, nithiazine, nornicotine, O-5-dichloro-4-iodophenyl O-ethyl ethylphosphonothioate, O,O-diethyl O-4-methyl-2-oxo-2H-chromen-7-yl phosphorothioate, O,O-diethyl O-6-methyl-2-propanol propylpyrimidin-4-yl phosphorothioate, O,O,O',O'-tetrapropyldithiopyrophosphate, oleic acid, para-dichlorobenzene, parathion-methyl, pentachlorophenol, pentachlorophenyl laurate, PH60-38, fenkapton, phosnichlor, phosphine, phoxim-methyl, pyrimetaphos, polychlorodicyclopentadiene isomers, potassium arsenite, potassium thiocyanate, precocene I, precocene II, precocene III, pyrimidophos, profluthrin, promecarb, prothiophos, pyrazophos s, pyresmethrin, cassia, quinalphos-methyl, quinothione, rafoxanide, resmethrin, rotenone, cadethrin, ryania, ryanodine, sabadilla), shradan, cebufos, SI-0009, thiapronil, sodium arsenite, sodium cyanide, sodium fluoride, sodium hexafluorosilicate, sodium pentachlorophenoxide salt, sodium selenate, sodium thiocyanate, sulcofuron, sulcofuron-sodium, sulfuryl fluoride, sulprofos, tar oil, thionazine, TDE, tebupirimfos, temephos,Tetraallethrin, tetrachloroethane, cyclophos, thiocyclam, thiocyclam hydrogen oxalate, thionazine, thiosultap, thiosultap-sodium, tralomethrin, transpermethrin, triazamate, trichlormethaphos-3, trichloronato, trimethacarb, tolprocarb, triclopyricarb, triplen, veratridine, veratrine, XMC, zetamethrin, zinc phosphide, zolaprophos and meperfluthrin, tetramethylfluthrin, bis(tributyltin) oxide, bromoacetamide, ferric phosphate, niclosamide-olamine, Tributyltin oxide, pyrimorph, triphenmorph, 1,2-dibromo-3-chloropropane, 1,3-dichloropropene, 3,4-dichlorotetrahydrothiophene 1,1-dioxide, 3-(4-chlorophenyl)-5-methylrhodanine, 5-methyl-6-thioxo-1,3,5-thiadiazinan-3-ylacetic acid, 6-isopentenylaminopurine, 2-fluoro-N-(3-methoxyphenyl)-9H-purin-6-amine, benclothiaz, cytokinin, DCIP, rufural, isamidophos, kinetin, Myrothecium verrucaria composition, tetrachlorothiophene, xylenol, zeatin, potassium ethylxanthate, acibenzolar, acibenzolar-S-methyl, Reynoutria sachalinensis extract, alpha-chlorohydrin, anth, Barium carbonate, bisthiosemi, brodifacoum, bromadiolone, bromethalin, chlorophacinone, cholecalciferol, coumachlor, coumafuryl, coumatetralyl, crimidine, difenacoum, difethialone, diphacinone, ergocalciferol, flocoumafen, fluoroacetamide, flupropazine, flupropazine hydrochloride, norbormide, fosacetim, phosphorus, pindone, pyrinuron, sciriloside, sodium fluoroacetate, thallium sulfate, warfarin, 2-(2-butoxyethoxy)ethyl piperonylate, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone, farnesol + nerolidol, berubutin, MGK 264, piperonyl butoxide, piprotal, propyl isomer, S421, sesamex, sesamolin, sulfoxide, anthraquinone, copper naphthenate, copper oxychloride, dicyclopentadiene, thiram, zinc naphthenate, ziram, imanin, ribavirin, mercury(II) oxide, thiophanate-methyl, azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, furametpyr, hexaconazole, imazalil, imibenconazole, ipconazole, metconazole, myclobutanil, paclobutrazol, pefurazoate, penconazole, prothioconazole, pyrifenox, proclo Raz, propiconazole, pyrisoxazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triflumizole, triticonazole, ancymidol, fenarimol, nuarimol, bupirimate, dimethirimol, ethirimol, dodemorph, fenpropidin, fenpropimorph, spiroxamine, tridemorph, cyprodinil, mepanipyrim, pyrimethanil, fenpiclonil, fludioxonil, benalaxyl, furalaxyl, metalaxyl, R-metalaxyl, ofrace, oxadixyl, carbendazim, debacarb, fuberidazole, thiabendazole, chlozolinate, dichlozolin, mycozolin, procymidone, vinclozolin, boscalid, carboxin, fenfuram, flutolanil,Mepronil, oxycarboxin, penthiopyrad, thifluzamide, dodine, iminoctadine, azoxystrobin, dimoxystrobin, enestrobulin, phenaminestrobin, flufenoxystrobin, fluoxastrobin, kresoxim-methyl, metominostrobin, trifloxystrobin, oryzastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, ferbam, mancozeb, maneb, metiram, propineb, zineb, captafol, captan, fluoroimi , folpet, tolylfluanid, Bordeaux mixture, copper oxide, mancopper, oxine copper, nitrothal-isopropyl, edifenphos, iprobenfos, phosdifen, turcophos-methyl, anilazine, benthiavalicarb, blasticidin-S, chloroneb, chlorothalonil, cyflufenamid, cymoxanil, cyclobutrifluram, diclocymet, diclomedine, dicloran, diethofencarb, dimethomorph, flumorph, dithianon, ethaboxam, etridiazole, famoxadone, fenamidone, fenoxa Nil, ferimzone, fluazinam, fluopicolide, flusulfamide, fluxapyroxad, fenhexamid, fosetyl-aluminum, hymexazole, iprovalicarb, cyazofamid, methasulfocarb, metrafenone, pencycuron, phthalide, polyoxin, propamocarb, pyribencarb, proquinazid, pyroquilon, pyriophenone, quinoxyfen, quintozene, tiadinil, triazoxide, tricyclazole, triforine, validamycin, valifenalate, zoxamide, mandipropamid, fulve tetraam, isopyrazam, sedaxane, benzovindiflupyr, pydiflumetofen, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2-yl)-amide, isoflucipram, isotianil, dipimethitrone, 6-ethyl-5,7-dioxo-pyrrolo[4,5][1,4]dithiino[1,2-c]isothiazole-3-carbonitrile, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide,4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine-3-carbonitrile, (R)-3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide, 4-(2-bromo-4-fluoro-phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5-dimethyl-pyrazol-3-amine, 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, Fluindapyr , methoxystrobin (jiaxiangjunzhi), lvbenmixianan, diclobenthiazox, mandestrobin, 3-(4,4-difluoro-3,4-dihydro-3,3-dimethylisoquinolin-1-yl)quinolone, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol, oxathiapiproline, tert-butyl N-[6-[[[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxy] Dimethyl]-2-pyridyl]carbamate, pyraziflumide, impirfluxam, tulorprocarb, mefentrifluconazole, ipfentrifluconazole, 2-(difluoromethyl)-N-[(3R)-3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide, N'-(2,5-dimethyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine, N'-[4-(4,5-dichlorothiazol-2-yl)oxy-2,5-dimethyl-phenyl]-N-ethyl-N-methyl-formamidine , [2-[3-[2-[1-[2-[3,5-bis(difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]thiazol-4-yl]-4,5-dihydroisoxazol-5-yl]-3-chloro-phenyl]methanesulfonic acid, but-3-ynyl N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate, methyl N-[[5-[4-(2,4-dimethylphenyl)triazol-2-yl]-2-methyl-phenyl]methyl]carbamate,3-chloro-6-methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazine, pyridaclomethyl, 3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide, 1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(3,4,5-trimethylpyrazol-1-yl)phenoxy]methyl]phenyl]tetrazol-5-one, aminopyrifen, amethoctrazine, amisulbrom, penflufen, (Z,2E)-5 -[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide, florylpicoxamide, fenpicoxamide, tebufloquine, ipulfenoquine, quinofumelin, isofetamide, N-[2-[2,4-dichloro-phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide, N-[2-[2-chloro-4-(trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide, benzothiostrobin, fenamacril, 5-amino-1,3,4-thiadiazole-2-thiol zinc salt (2:1), Fluopyram, Flutianil, Fluopimomide, Pyrapropoin, Picarburazox, 2-(difluoromethyl)-N-(3-ethyl-1,1-dimethyl-indan-4-yl)pyridine-3-carboxamide, 2-(difluoromethyl)-N-((3R)-1,1,3-trimethylindan-4-yl)pyridine-3-carboxamide, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3- (1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile, methyltetraprole, 2-(difluoromethyl)-N-((3R)-1,1,3-trimethylindan-4-yl)pyridine-3-carboxamide, α-(1,1-dimethylethyl)-α-[4'-(trifluoromethoxy)[1,1'-biphenyl]-4-yl]-5-pyrimidinemethanol, fluoxapiproline, enoxastrobin, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile, 4-[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-sulfanyl-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile, 4-[[6-[2-(2, 4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thioxo-4H-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile, trinexapac, cumoxystrobin, zhongshengmycin, copper thiodiazole, zinc thiazole, amethotractin, iprodione, N-octyl-N'-[2-(octylamino)ethyl]ethane-1,2-Diamine, N'-[5-bromo-2-methyl-6-[(1S)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxy-ethoxy]-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxy-ethoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine N'-[5-bromo-2-methyl-6-(2-propoxypropoxy)-3-pyridyl]-N-ethyl-N-methyl-formamidine (this compound can be prepared from the method described in IPCOM000249876D); N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenyl-ethyl)phenyl]-N-methyl-formamidine, N'-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxy-ethyl)-5-methoxy-2-methyl-phenyl]-N-isopropyl-N-methyl-formamidine (these compounds can be prepared according to the method described in WO 2018 / 228896); N-ethyl-N'-[5-methoxy-2-methyl-4-[2-trifluoromethyl)oxetan-2-yl]phenyl]-N-methyl-formamidine, N-ethyl-N'-[5-methoxy-2-methyl-4-[2-trifluoromethyl)tetrahydrofuran-2-yl]phenyl ]-N-methyl-formamidine (these compounds can be prepared according to the method described in WO 2019 / 110427); N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro-quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8-difluoro-quinoline-3-carboxamide, 8-Fluoro-N-[(1R)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide 8-Fluoro-N-[(1S)-1-[(3-fluorophenyl)methyl]-1,3-dimethyl-butyl]quinoline-3-carboxamide, N-[(1R)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide, N-((1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide (these compounds can be prepared according to the method described in WO 2017 / 153380); 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, -yl)-4,4,6-trifluoro-3,3-dimethyl-isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(6-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 4,4-difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline, 1-(6-chloro-7-methyl-pyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3 ,3-dimethyl-isoquinoline (these compounds can be prepared according to the method described in WO 2017 / 025510); 1-(4,5-dimethylbenzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline, 1-(4,5-dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline, 6-chloro-4,4-difluoro-3,3-dimethyl-1 -(4-methylbenzimidazol-1-yl)isoquinoline, 4,4-difluoro-1-(5-fluoro-4-methyl-benzimidazol-1-yl)-3,3-dimethyl-isoquinoline, 3-(4,4-difluoro-3,3-dimethyl-1-isoquinolyl)-7,8-dihydro-6H-cyclopenta[e]benzimidazole (these compounds can be prepared according to the method described in WO 2016 / 156085);N-Methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 1-Methoxy-3-methyl-1-[[4-[5-(trifluoromethyl) 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrazole-4-carboxylate, N,N-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, -yl]phenyl]methyl]-1,2,4-triazol-3-amine (these compounds can be prepared from the methods described in WO 2017 / 055473, WO 2017 / 055469, WO 2017 / 093348 and WO 2017 / 118689); 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol (this compound can be prepared from the methods described in WO 2017 / 029179);2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol (this compound can be prepared from the method described in WO 2017 / 029179); 3-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]imidazole-4-carbonitrile (this compound can be prepared from the method described in WO 2016 / 156290); 3-[2-(1-chlorocyclopropyl)-3-(3-chloro (4-phenoxyphenyl)methyl 2-amino-6-methyl-pyridine-3-carboxylate (this compound can be prepared from the method described in WO 2014 / 006945); 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetrone (this compound can be prepared from the method described in WO 2014 / 006945); N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarbothioamide (which can be prepared from the method described in WO 2011 / 138281); N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide; (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide (this compound can be prepared from the method described in WO 2018 / 153707); N'- (2-chloro-5-methyl-4-phenoxy-phenyl)-N-ethyl-N-methyl-formamidine; N'-[2-chloro-4-(2-fluorophenoxy)-5-methyl-phenyl]-N-ethyl-N-methyl-formamidine (this compound can be prepared from the method described in WO 2016 / 202742); 2-(difluoromethyl)-N-[(3S)-3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide (this compound can be prepared from the method described in WO 2014 / 095675);(5-methyl-2-pyridyl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone, (3-methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methanone (these compounds can be prepared from the method described in WO 2017 / 220485); 2-oxo-N-propyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide (these compounds can be prepared from the method described in WO 2018 / 065414); ethyl 1-[[5-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]pyrazole-4-carboxylate acetamide, N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, N-[N-methoxy-C-methyl-carbonimidoyl ...
[0127] The compounds of the present invention may also be used in combination with anthelmintic drugs. Such anthelmintics include compounds selected from the macrocyclic lactone class of compounds such as ivermectin, avermectin, abamectin, emamectin, epirimectin, doramectin, selamectin, moxidectin, nemadectin and milbemycin derivatives, as described in EP 357460, EP 444964 and EP 594291. Additional anthelmintics include semi-synthetic and biosynthetic avermectin / milbemycin derivatives, such as those described in US Pat. No. 5,015,630, WO 9415944 and WO 9522552. Additional anthelmintics include benzimidazoles such as albendazole, cambendazole, fenbendazole, flubendazole, mebendazole, oxyfendazole, oxybendazole, parbendazole and other members of this class. Additional anthelmintics include imidazothiazoles and tetrahydropyrimidines such as tetramisole, levamisole, pyrantel pamoate, oxantel or morantel. Additional anthelmintics include fluoxamides such as triclabendazole and clorsulon and cestocides such as praziquantel and epsiprantel.
[0128] The compounds of the present invention may be used in combination with derivatives and analogues of the paraherquamide / marcfortine class of anthelmintics and antiparasitic oxazolines such as those disclosed in U.S. Pat. No. 5,478,855, U.S. Pat. No. 4,639,771 and German Patent No. 19520936.
[0129] The compounds of the invention may be used in combination with derivatives and analogues of the general class of dioxomorpholine antiparasitic agents described in WO 9615121, and in combination with anthelmintic active cyclic depsipeptides such as those described in WO 9611945, WO 9319053, WO 9325543, EP 626375, EP 382173, WO 9419334, EP 382173 and EP 503538.
[0130] The compounds of the invention may be used in combination with other ectoparasiticides; for example fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide; neonicotinoids such as imidacloprid.
[0131] The compounds of the present invention may be used in combination with terpene alkaloids, particularly those disclosed in WO 95 / 19363 or WO 04 / 72086.
[0132] Other examples of such biologically active compounds with which the compounds of the present invention may be used in combination include, but are not limited to, the following: Organophosphates: Acephate, Azamethiphos, Azinphos-ethyl, Azinphos-methyl, Bromophos, Bromophos-ethyl, Cadusafos, Chlorethoxyphos, Chlorpyrifos, Chlorfenvinphos, Chlormephos, Demeton, Demeton-S-methyl, Demeton-S-methylsulfone, Diarifos, Diazinon, Dichlorvos, Dicrotophos, Dimethoate, Disulfoton, Ethion, Ethoprophos, Etrimphos, Fanfur, Fenamiphos, Fenitrothion, Fensulfothion, Fenthion, Flupyrazophos, Fonophos, Formothion, Fosthiazate, Heptenophos, Isazophos, Isothioate, Isoxathioate , malathion, methacrifos, methamidophos, methidathion, methyl-parathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, paraoxon, parathion, parathion-methyl, phenthoate, phosalone, phospholane, phosphocarb, phosmet, phosphamidon, phorate, phoxim, pirimiphos, pirimiphos-methyl, profenofos, propafos, proethamphos, prothiofos, pyraclofos, pyridapenthione, quinalphos, sulprofos, temephos, terbufos, tebupirimphos, tetrachlorvinphos, thimeton, triazophos, trichlorfon, vamidothion.
[0133] Carbamates: alanycarb, aldicarb, 2-sec-butylphenyl methylcarbamate, benfuracarb, carbaryl, carbofuran, carbosulfan, cloethocarb, ethiofencarb, fenoxycarb, fenthiocarb, furathiocarb, HCN-801, isoprocarb, indoxacarb, methiocarb, methomyl, 5-methyl-m-cumenylbutyryl (methyl)carbamate, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, UC-51717.
[0134] Pyrethroids: acrinathin, allethrin, alphamethrin, 5-benzyl-3-furylmethyl (E)-(1R)-cis-2,2-dimethyl-3-(2-oxothiolan-3-ylidenemethyl)cyclopropanecarboxylate, bifenthrin, beta-cyfluthrin, cyfluthrin, alpha-cypermethrin, beta-cypermethrin, bioallethrin, bioallethrin ((S)-cyclopentyl isomer), bioresmethrin, bifenthrin, NCI-85193, cycloprothrin, cyhalothrin , cycythrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, etofenprox, fenfluthrin, fenpropathrin, fenvalerate, flucythrinate, flumethrin, fluvalinate (D isomer), imiprothrin, cyhalothrin, λ-cyhalothrin, permethrin, fenothrin, prallethrin, pyrethrins (natural products), resmethrin, tetramethrin, transfluthrin, θ-cypermethrin, silafluofen, t-fluvalinate, tefluthrin, tralomethrin, ζ-cypermethrin.
[0135] Arthropod growth regulators: a) Chitin synthesis inhibitors: Benzoyl ureas: Chlorfluazuron, Diflubenzuron, Fluazuron, Flucycloxuron, Flufenoxuron, Hexaflumuron, Lufenuron, Novaluron, Teflubenzuron, Triflumuron, Buprofezin, Diofenolan, Hexythiazox, Etoxazole, Chlorfentadine; b) Ecdysone antagonists: Halofenozide, Methoxyfenozide, Tebufenozide; c) Juvenoids: Pyriproxyfen, Methoprene (including S-methoprene), Fenoxycarb; d) Lipid biosynthesis inhibitors: Spirodiclofen.
[0136] Other antiparasitic drugs: Acequinocyl, Amitraz, AKD-1022, ANS-118, Azadirachtin, Bacillus thuringiensis thuringiensis), bensultap, bifenazate, binapacryl, bromopropylate, BTG-504, BTG-505, camphechlor, cartap, chlorobenzilate, chlordimeform, chlorfenapyr, chromafenozide, clothianidine, cyromazine, diacloride, diafenthiuron, DBI-3204, dinactin, dihydroxymethyldihydroxypyrrolidine, dinobuton, dinocap, endosulfan, ethiprole, etofenprox, fenazaquin, flumite, MTI-800, fenpyroximate, fluacrypyrim, flubenzimine, flubrocythrinate, fluphenzin, flufenprox, fluproxifen, halofenprox ofenprox), hydramethylnon, IKI-220, Kanemite, NC-196, Nimgard, Nidinolterfuran, Nitenpyram, SD-35651, WL-108477, pyridalyl, propargite, protrifenbut, pymethrozine, pyridaben, pyrimidifen, NC-1111, R-195, RH-0345, RH-2485, RYI-210, S-1283, S-1833, SI-8601, silafluofen, cyromazine, spinosad, tebufenpyrad, tetradifon, tetranactin, thiacloprid, thiocyclam, thiamethoxam, tolfenpyrad, triazamate, triethoxyspinosin, trinactin, belbutin, bertarek, YI-5301.
[0137] Biological agents: Bacillus thuringiensis ssp aizawai, kurstaki, Bacillus thuringiensis delta endotoxin, baculovirus, entomopathogenic bacteria, viruses and fungi.
[0138] Fungicides: Chlortetracycline, oxytetracycline, streptomycin.
[0139] Other biological agents: Enrofloxacin, Febantel, Penethamate, Moroxicam, Cephalexin, Kanamycin, Pimobendan, Clenbuterol, Omeprazole, Tiamulin, Benazepril, Pyriprole, Cefquinome, Florfenicol, Buserelin, Cefovecin, Tulathromycin, Ceftiowol, Carprofen, Metaflumizone, Praziquarantel, Triclabendazole.
[0140] Another aspect of the invention relates to the use of a compound of formula (I) or a preferred individual compound as defined above, a composition comprising at least one compound of formula (I) or at least one preferred individual compound as defined above or a fungicidal or insecticidal mixture comprising at least one compound of formula (I) or at least one preferred individual compound as defined above, in admixture with other fungicides or insecticides as defined above, for controlling or preventing infestation on plants, e.g. useful plants, such as crop plants, their propagation products, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living material by phytopathogenic microorganisms, e.g. insects or preferably fungal organisms.
[0141] A further aspect of the invention relates to a method for controlling or preventing infestation on plants, e.g. useful plants, such as crop plants, their propagation materials, e.g. seeds, harvested crops, e.g. harvested food crops, or non-living material by phytopathogenic or spoilage microorganisms or organisms, such as insects or especially fungal organisms, that are potentially harmful to humans, which method comprises the step of applying a compound of formula (I) or a preferred individual compound as defined above as active ingredient to the plant, to a part of the plant or its habitat, to its propagation materials or to any part of the non-living material.
[0142] By control or prevention is meant reducing infestation by plant pathogenic or spoilage microorganisms or organisms that are potentially harmful to humans, such as insects or especially fungal organisms, to a level that demonstrates an improvement.
[0143] A preferred method for controlling or preventing infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, or insects, which involves the application of a compound of formula (I) or an agrochemical composition containing at least one of said compounds, is foliar treatment. The frequency and amount of application will depend on the risk of infestation by the corresponding pathogen or insect. However, the compound of formula (I) can also be introduced into the plant by the roots via the soil (systemic action) by irrigating the plant habitat with a liquid formulation or by applying the compound to the soil in solid form, for example in granular form (soil application). In the case of rice crops, such granules can be applied to flooded rice fields. The compound of formula (I) can be applied to the seeds (coating) by impregnating the seeds or tubers with a liquid formulation of the fungicide or coating them with a solid formulation.
[0144] Formulations, e.g. compositions containing a compound of formula (I) and, optionally, a solid or liquid auxiliary or monomer that encapsulates the compound of formula (I), may be prepared in a known manner, typically by homogeneously mixing and / or grinding the compounds together with extenders, e.g. solvents, solid carriers and, optionally, surface-active compounds (surfactants).
[0145] Advantageous application rates are usually from 5 g to 2 kg of active ingredient (ai) per hectare (ha), preferably from 10 g to 1 kg ai / ha, most preferably from 20 g to 600 g ai / ha.When used as a seed drench, a convenient dosage is from 10 mg to 1 g of active substance per kg of seeds.
[0146] When the combinations of the invention are used for seed treatment, an amount of 0.001 to 50 g of a compound of formula (I) per kg of seed, preferably 0.01 to 10 g per kg of seed, will generally be sufficient.
[0147] The compositions of the present invention may be in any conventional form, such as, for example, a two-part system, a dry seed treatment powder (DS), a seed treatment emulsion (ES), a seed treatment flowable concentrate (FS), a seed treatment solution (LS), a seed treatment water dispersible powder (WS), a seed treatment capsule suspension (CF), a seed treatment gel (GF), an emulsion concentrate (EC), a suspension concentrate (SC), a suspoemulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (WG), a water dispersible ... They may be employed in the form of granules (EG), emulsions, water-in-oil (EO), emulsions, oil-in-water (EW), microemulsions (ME), oil dispersions (OD), oil-miscible fluids (OF), oil-miscible liquids (OL), soluble concentrates (SL), ultra-low volume suspensions (SU), ultra-low volume liquids (UL), technical concentrates (TK), dispersible concentrates (DC), wettable powders (WP) or any technically desirable formulation in combination with agriculturally acceptable adjuvants.
[0148] Such compositions can be produced in a conventional manner, for example by mixing the active ingredient with suitable inert ingredients (diluents, solvents, fillers and optional other ingredients such as surfactants, biocides, antifreeze agents, spreading agents, thickeners and compounds that provide adjuvant activity effects). Conventional slow-release formulations can also be employed when long-lasting efficacy is intended. In particular, formulations applied in spray form, such as water-dispersible concentrates (e.g., EC, SC, DC, OD, SE, EW, EO, etc.), wettable powders and granules, can contain surfactants such as wetting and dispersing agents and other compounds that provide adjuvant effects, such as, for example, condensates of formaldehyde with naphthalene sulfonates, alkylaryl sulfonates, lignin sulfonates, fatty alkyl sulfates and ethoxylated alkylphenols and ethoxylated fatty alcohols.
[0149] The seed dressing formulation is applied to the seed in a manner known per se, utilizing the combination and diluent of the present invention in a suitable seed dressing formulation form, such as an aqueous suspension or a dry powder form with good adhesion to the seed. Such seed dressing formulations are known in the art. The seed dressing formulation may contain a single active ingredient or may contain a combination of active ingredients in encapsulated form, for example as a slow release capsule or microcapsule.
[0150] Typically, the formulations contain 0.01-90% by weight of active agent, 0-20% of agriculturally acceptable surfactants and 10-99.99% of solid or liquid inert compounding agents and adjuvants, the active agent being at least the compound of formula (I) together with components (B) and (C) and optionally other active agents, in particular fungicides or preservatives. Concentrated forms of the composition generally contain about 2-80%, preferably about 5-70% by weight of active agent. Application forms of the formulations may contain, for example, 0.01-20% by weight, preferably 0.01-5% by weight of active agent. Commercially available products will preferably be formulated as concentrates, but end users will usually utilize diluted formulations.
[0151] Table 1 below illustrates examples of individual compounds of formula (I) according to the invention.
[0152] [Table 1-1] [Table 1-2] [Table 1-3] [Table 1-4] [Table 1-5] [Table 1-6]
[0153] Where: a) Formula (Ia): [ka] 260 compounds, where R 2 and R 4 is as defined in Table 1.
[0154] b) Formula (Ib): [ka] 260 compounds, where R 2 and R 4 is as defined in Table 1.
[0155] c) Formula (Ic): [ka] 260 compounds, where R 2 and R 4 is as defined in Table 1.
[0156] d) Formula (Id): [ka] 260 compounds, where R 2 and R 4 is as defined in Table 1.
[0157] e) Formula (Ie): [ka] 260 compounds, where R 2 and R 4 is as defined in Table 1.
[0158] [Table 2]
[0159] Where: f) Expression (If): [ka] There are eight compounds, where R 1 , R 2 and R 4 is as defined in Table 2.
[0160] g) Formula (Ig): [ka] There are eight compounds, where R 1 , R 2 and R 4 is as defined in Table 2.
[0161] h) Formula (Ih): [ka] There are eight compounds, where R 1 , R 2 and R 4 is as defined in Table 2.
[0162] j) Formula (Ij): [ka] There are eight compounds, where R 1 , R 2 and R 4 is as defined in Table 2.
[0163] k) Formula (Ik): [ka] There are eight compounds, where R1 , R 2 and R 4 is as defined in Table 2. EXAMPLES
[0164] Formulation Examples
[0165] [Table 3]
[0166] The active ingredient was thoroughly mixed with the adjuvants and the mixture was thoroughly ground in a suitable mill to obtain a wettable powder which can be diluted with water to provide a suspension of the desired concentration.
[0167] [Table 4]
[0168] The active ingredient was thoroughly mixed with the adjuvant and the mixture was thoroughly ground in a suitable mill to obtain a powder which can be directly used for seed treatment.
[0169] emulsifiable concentrate Active ingredient [compound of formula (I)] 10% Octylphenol polyethylene glycol ether 3% (4-5 mol of ethylene oxide) Calcium dodecylbenzenesulfonate 3% Castor oil polyglycol ether (35 mol ethylene oxide) 4% Cyclohexanone 30% Xylene Mixture 50%
[0170] Emulsions of any required dilution which can be used in plant protection can be obtained from this concentrate by dilution with water.
[0171] [Table 5]
[0172] Ready-to-use dusts can be obtained by mixing the active ingredient with a carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressing of seeds.
[0173] Extrusion Granules Active ingredient [compound of formula (I)] 15% Sodium Lignosulfonate 2% Carboxymethylcellulose 1% Kaolin 82%
[0174] The active ingredient is mixed with the auxiliaries and ground, the mixture is moistened with water, the mixture is extruded and then dried in a current of air.
[0175] Coated Granules Active ingredient [compound of formula (I)] 8% Polyethylene glycol (mol.wt.200) 3% Kaolin 89%
[0176] The finely ground active ingredient is applied uniformly in a mixer to the kaolin moistened with polyethylene glycol. Dust-free coated granules are thus obtained.
[0177] Suspension concentrate Active ingredient [compound of formula (I)] 40% Propylene glycol 10% Nonylphenol polyethylene glycol ether (15 mol ethylene oxide) 6% Sodium Lignosulfonate 10% Carboxymethylcellulose 1% Silicone oil (in the form of a 75% emulsion in water) 1% water 32%
[0178] The finely ground active ingredient is mixed homogeneously with the auxiliaries to obtain a suspension concentrate, which can be diluted with water to obtain any desired concentration, and can be used to treat and protect living plants and plant propagation material from microbial infestation by spraying, pouring or immersion.
[0179] Flowable concentrates for seed treatment Active ingredient [compound of formula (I)] 40% Propylene glycol 5% Copolymer butanol PO / EO 2% Tristyrene phenol with 10-20 moles of EO 2% 1,2-Benzisothiazolin-3-one (in the form of a 20% aqueous solution) 0.5% Monoazo-pigment calcium salt 5% Silicone oil (in the form of a 75% emulsion in water) 0.2% Water 45.3%
[0180] The finely ground active ingredient is mixed homogeneously with the auxiliaries to obtain a suspension concentrate, which can be diluted with water to obtain any desired concentration, and can be used to treat and protect living plants and plant propagation material from microbial infestation by spraying, pouring or immersion.
[0181] Slow-release capsule suspension 28 parts of the combined compounds of formula (I) are mixed with 2 parts of an aromatic solvent and 7 parts of a toluene diisocyanate / polymethylene-polyphenylisocyanate mixture (8:1). The mixture is emulsified in a mixture of 1.2 parts of polyvinyl alcohol, 0.05 parts of a defoamer, and 51.6 parts of water until the desired particle size is achieved. A mixture of 2.8 parts of 1,6-diaminohexane in 5.3 parts of water is added to the emulsion. The mixture is stirred until the polymerization reaction is complete.
[0182] The resulting capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersant. The capsule suspension formulation contains 28% active ingredient. The medium capsule size is 8-15 microns.
[0183] The resulting formulation is applied to the seeds as an aqueous suspension in equipment suitable for that purpose.
[0184] The following examples are provided to illustrate the present invention.The compounds of the present invention can be distinguished from known compounds by their high efficacy at low application rates, which can be verified by those skilled in the art using the experimental procedures outlined in the examples, using low application rates such as 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm, 0.8 ppm or 0.2 ppm as necessary.
[0185] The compounds of formula (I) may have many benefits including, inter alia, advantageous levels of biological activity or superior properties for use as agrochemical active ingredients (e.g. high biological activity, advantageous spectrum of activity, enhanced safety profile (including improved crop tolerance), improved physicochemical properties or increased biodegradability) for protecting plants against diseases caused by fungi.
[0186] List of Abbreviations °C = degrees Celsius, CDCl3 = chloroform-d, d = doublet, DIPEA = N,N-diisopropylethylamine, DMF = dimethylformamide, HAUT = 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate, m = multiplet, MHz = megahertz, N = normal, s = singlet
[0187] Example 1: This example illustrates the preparation of 6-(3,5-difluoroanilino)-N-(2,2-dimethylpropyl)-3-methoxy-pyrazine-2-carboxamide (compound P-39, Table 3). [ka]
[0188] a) Preparation of methyl 6-bromo-3-methoxy-pyrazine-2-carboxylate [ka] Methyl 3-amino-6-bromo-pyrazine-2-carboxylate (1.0 g, 4.31 mmol) was dissolved in concentrated sulfuric acid (5.86 mL) and the mixture was stirred at 0° C. Sodium nitrite (2.0 equiv.) was then added and the reaction was stirred at 0° C. for 30 min. The mixture was slowly poured into methanol (53 mL) at room temperature and the resulting mixture was stirred for an additional 5 h. Methanol was then distilled off and the residue was poured into ice-cold water (100 mL). The aqueous phase was extracted three times with dichloromethane and the combined organic phase was washed with saturated aqueous sodium bicarbonate, brine and then dried over sodium sulfate. Volatiles were removed in vacuum and the crude product was purified by chromatography on silica gel (eluent: cyclohexane-ethyl acetate mixture). The desired methyl 6-bromo-3-methoxy-pyrazine-2-carboxylate was obtained. 1 H-NMR (400MHz, (CD3)2SO): δ = 3.87 (s, 3H), 3.98 (s, 3H), 8.19 (s, 1H).
[0189] b) Preparation of methyl 6-(3,5-difluoroanilino)-3-methoxy-pyrazine-2-carboxylate [ka] Under an argon atmosphere, BrettPhos-G3-Palladacycle ([(2-di-cyclohexylphosphino-3,6-dimethoxy-2',4',6'-triisopropyl-1,1'-biphenyl)-2-(2'-amino-1,1'-biphenyl)]palladium(II) methanesulfonate, 0.1 equiv.) and cesium carbonate (2.5 equiv.) were added to a degassed, stirred mixture of methyl 6-bromo-3-methoxy-pyrazine-2-carboxylate (2.0 g, 8.1 mmol, 1 equiv.) and 3,5-difluoroaniline (1.1 equiv.) in THF (32.5 mL). The reaction was heated to 80° C. and stirred for 1 h, then the mixture was cooled to room temperature. The volatiles were removed using a rotary evaporator and the residue was dissolved in ethyl acetate. The organic phase was washed twice with water, dried over anhydrous sodium sulfate and concentrated in vacuo. Purification by column chromatography on silica gel (eluent: cyclohexane-ethyl acetate mixture) gave the desired methyl 6-(3,5-difluoroanilino)-3-methoxy-pyrazine-2-carboxylate. 1 H-NMR (400MHz, (CD3)2SO): δ=3.85(s,3H),3.92(s,3H),6.60~6.70(m,1H),7.40~7.50(m,2H),8.16(s,1H).
[0190] c) Preparation of 6-(3,5-difluoroanilino)-3-methoxy-pyrazine-2-carboxylic acid [ka] Lithium hydroxide monohydrate (4 equiv.) was added to a solution of methyl 6-(3,5-difluoroanilino)-3-methoxy-pyrazine-2-carboxylate (2.10 g, 3.16 mmol) in a mixture of tetrahydrofuran (72 mL) and water (36 mL). The reaction mixture was stirred at room temperature for 1 h, then the solvent was removed in vacuo. The residue was diluted with ethyl acetate and water, then 2N hydrochloric acid was added slowly until a pH of 2-3 was reached. The phases were separated and the aqueous layer was extracted three times with ethyl acetate. The combined organic phases were then dried over sodium sulfate and all volatiles were evaporated using a rotary evaporator. The resulting 6-(3,5-difluoroanilino)-3-methoxy-pyrazine-2-carboxylic acid was used directly in the next step without further purification.
[0191] d) Preparation of 6-(3,5-difluoroanilino)-N-(2,2-dimethylpropyl)-3-methoxy-pyrazine-2-carboxamide (compound P-39, Table 3) [ka] 2,2-Dimethylpropan-1-amine (1.1 eq.), 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU, 1.1 eq.) and N,N-diisopropylethylamine (2.6 eq.) were added sequentially to a solution of 6-(3,5-difluoroanilino)-3-methoxy-pyrazine-2-carboxylic acid (70 mg, 0.25 mmol, 1 eq.) in DMF (2.5 mL). The resulting solution was stirred at room temperature for 2 h until the starting material was consumed (LCMS control). Then, a saturated solution of NaHCO3 was added to the mixture, the solution was extracted three times with ethyl acetate, the organic phases were combined, dried over sodium sulfate and all volatiles were removed by rotary evaporation. Purification by column chromatography on silica gel (eluent: cyclohexane / ethyl acetate mixtures) gave the desired product 6-(3,5-difluoroanilino)-N-(2,2-dimethylpropyl)-3-methoxy-pyrazine-2-carboxamide. 1<h2 style=";text-align:left;direction:ltr">H-NMR(400MHz,CDCl3):d=1.02(s,9H),3.30(d,2H),4.02(s,3H),6.35~6.45(m,1H),7.00~7.10(m,2H),7.75~7.85(m,2H),8.16(s,1H)。<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">
[0192] <h2 style=";text-align:left;direction:ltr"> Throughout this specification, temperatures are given in degrees Celsius (°C) and "mp" means melting point. LC / MS means liquid chromatography mass spectrometry, and the description of the apparatus and methods are as follows: (Method A: ACQUITY UPLC from Waters, Waters UPLC HSS T3, 1.8 μm particle size, 30×2.1 mm column, 0.85 mL / min, 60°C, H2O / MeOH 95:5+0.05% HCOOH(90%) / CH3CN+0.05% HCOOH(10%) - 1.2 min - CH3CN+0.05% HCOOH(100%) - 0.30 min, ACQUITY from Waters SQD mass spectrometer, ionization method: electrospray (ESI), polarity: positive ion, capillary (kV) 3.00, cone (V) 30.00, extractor (V) 2.00, source temperature (°C) 150, desolvation temperature (°C) 350, cone gas flow (L / Hr) 0, desolvation gas flow (L / Hr) 650). Method B: Waters ACQUITY UPLC, Waters UPLC HSS T3, 1.8 μm particle size, 30×2.1 mm column, 0.85 mL / min, 60° C., HO / MeOH 95:5+0.05% HCOOH(90%) / CHCN+0.05% HCOOH(10%) - 2.7 min - CHCN+0.05% HCOOH(100%) - 0.30 min, Waters ACQUITY SQD mass spectrometer, Ionization: electrospray (ESI), Polarity: positive ion, Capillary (kV) 3.00, Cone (V) 30.00, Extractor (V) 2.00, Source Temp (° C.) 150, Desolvation Temp (° C.) 350, Cone Gas Flow (L / Hr) 0, Desolvation Gas Flow (L / Hr) 650). Method C: A Waters Corporations ACQUITY mass spectrometer (SQD or SQDII single quadrupole mass spectrometer) equipped with an electrospray source (polarity: positive or negative, capillary: 3.0 kV, cone: 30 V, extractor: 3.00 V, source temperature: 150° C., desolvation temperature: 400° C., cone gas flow: 60 L / hr, desolvation gas flow: 700 L / hr, mass range: 140-800 Da) and a Waters Corporations ACQUITY UPLC equipped with a solvent degasser, binary pump, heated column compartment and a diode-array detector.Column: Waters UPLC HSS T3, 1.8 μm, 30 × 2.1 mm; temperature: 60 °C; DAD wavelength range (nm): 210–400; solvent gradient: A = water / methanol 9:1 + 0.1% formic acid, B = acetonitrile + 0.1% formic acid; gradient: 0 to 100% B in 2.5 min; flow rate (ml / min) 0.75).
[0193] [Table 6-1] [Table 6-2] [Table 6-3] [Table 6-4] [Table 6-5] [Table 6-6] [Table 6-7] [Table 6-8] [Table 6-9] [Table 6-10] [Table 6-11]
[0194] Biological Examples Example B1: Alternaria solani / tomato / leaf disc (summer blight) Tomato leaf discs (cv. Baby) are placed on agar in multi-well plates (24-well type) and sprayed with the formulated test compounds diluted in water. Two days after application, the leaf discs are inoculated with a fungal spore suspension. The inoculated leaf discs are incubated in a climate cabinet at 23°C / 21°C (day / night) and 80% relative humidity under a 12 / 12 h (light / dark) light regime, and the activity of the compounds is evaluated as the percentage disease control compared to untreated when an appropriate level of disease damage appears on the untreated test leaves (5-7 days after application). The following compounds provided at least 80% control of Alternaria solani at 200 ppm when compared under the same conditions to an untreated control which showed significant disease incidence: P-4, P-5, P-9, P-13, P-16, P-20, P-22, P-25, P-28, P-30, P-37, P-38, P-39, P-41, P-43 and P-44.
[0195] Example B2: Glomerella lagenarium (Colletotrichum lagenarium) / Liquid Culture (Anthracnose) Fungal conidia stored at cryogenic temperatures are mixed directly into nutrient liquid medium (PDB potato dextrose liquid medium). A (DMSO) solution of the test compound is placed in a microtiter plate (96-well format) followed by the addition of nutrient liquid medium containing fungal spores. The test plates are incubated at 24°C and growth inhibition is measured photometrically 3-4 days after application. The following compounds provided at least 80% control of Glomerella lagenarium at 20 ppm when compared under the same conditions with untreated controls that showed significant disease development: P-1, P-2, P-3, P-4, P-5, P-6, P-8, P-9, P-10, P-11, P-12, P-13, P-14, P-15, P-16, P-17, P-18, P-19, P-20, P-21, P-22, P-23. , P-24, P-25, P-26, P-27, P-28, P-29, P-30, P-31, P-32, P-33, P-34, P-35, P-36, P-37, P-38, P-39, P-40, P-41, P-43, P-44, P-45, P-46, P-47, P-48, P-49 and P-50.
[0196] Example B3: Blumeria graminis f.sp. tritici (Erysiphe graminis f.sp. tritici) / wheat / leaf flake prevention (powdery mildew in wheat) Wheat leaf segments (cv. Kanzler) are placed on agar in multi-well plates (24-well format) and sprayed with the formulated test compounds diluted in water. One day after application, powdery mildew-infected plants are inoculated onto the leaf segments by shaking them over the test plates. The inoculated leaf segments are incubated in a climate chamber at 20°C and 60% relative humidity under a light regime of 24 hours darkness followed by 12 hours light / 12 hours darkness, and the activity of the compounds is evaluated as the percentage disease control compared to untreated when an appropriate level of disease damage appears on the untreated test leaf segments (6-8 days after application). The following compounds provided at least 80% control of Blumeria graminis f.sp. tritici at 200 ppm when compared under the same conditions to an untreated control which showed significant disease incidence: P-4, P-5, P-8, P-9, P-16, P-20, P-21, P-22, P-24, P-25, P-28, P-30, P-35, P-37, P-38, P-39, P-40, P-41, P-43, P-44, P-45 and P-50.
[0197] Example B4: Phaeosphaeria nodorum (Septoria nodorum) / Wheat / Leaf disc preventive (Septoria nodorum) Wheat leaf slices (cv. Kanzler) are placed on agar in multi-well plates (24-well format) and sprayed with the formulated test compounds diluted in water. The leaves are inoculated with a fungal spore suspension 2 days after application. The inoculated test leaves are incubated in a climate cabinet under a 12-h light / 12-h dark photoperiod at 20°C and 75% relative humidity, and the activity of the compounds is evaluated as the percentage disease control compared to untreated when an appropriate level of disease damage appears on the untreated test leaves (5-7 days after application). The following compounds provided at least 80% control of Phaeosphaeria nodorum at 200 ppm when compared under the same conditions with untreated controls that showed significant disease development: P-29, P-38, P-43 and P-44.
[0198] Example B5: Monographella nivalis (Microdochium nivale) / Liquid culture (root rot of cereals) Fungal conidia stored at cryogenic temperatures are mixed directly into nutrient liquid medium (PDB potato dextrose broth). A (DMSO) solution of the test compound is placed in a microtiter plate (96-well format) and then the nutrient liquid medium containing the fungal spores is added. The test plates are incubated at 24°C and growth inhibition is measured photometrically 4-5 days after application. The following compounds provided at least 80% control of Monographella nivalis at 20 ppm when compared under the same conditions to an untreated control which showed significant disease incidence: P-1, P-2, P-3, P-4, P-5, P-6, P-7, P-8, P-9, P-10, P-11, P-12, P-13, P-14, P-15, P-16, P-17, P-18, P-19, P-20, P-21, P-22, P-24, P-25, P-29, P-30, P-32, P-37, P-38, P-39, P-40, P-41, P-42, P-43, P-44, P-45, P-46, P-47, P-48, P-49, and P-50.
[0199] Example B6: Mycosphaerella arachidis (Cercospora arachidicola) / liquid culture (early spot disease) Fungal conidia stored at cryogenic temperatures are mixed directly into nutrient liquid medium (PDB potato dextrose liquid medium). A (DMSO) solution of the test compound is placed in a microtiter plate (96-well format) followed by the addition of nutrient liquid medium containing fungal spores. The test plates are incubated at 24°C and growth inhibition is measured photometrically 4-5 days after application. The following compounds provided at least 80% control of Mycosphaerella arachidis at 20 ppm when compared under the same conditions with untreated controls that showed significant disease development: P-1, P-4, P-5, P-9, P-13, P-16, P-20, P-22, P-24, P-25, P-29, P-30, P-38, P-39, P-40, P-43, P-44, and P-48.
[0200] Example B7: Phakopsora pachyrhizi / soybean / preventative (soybean rust) Soybean leaf discs are placed on water agar in multi-well plates (24-well format) and sprayed with the formulated test compounds diluted in water. One day after application, the leaf discs are inoculated by spraying a spore suspension on the underside of the leaf. After a 24-36 hour incubation period in a climatic cabinet at 20°C and 75% relative humidity in the dark, the leaf discs are maintained at 20°C with 12 hours of light / day and 75% relative humidity. The activity of the compounds is evaluated as the percentage disease control compared to untreated when the appropriate level of disease damage appears on the untreated test leaf discs (12-14 days after application). The following compounds provided at least 80% control of Phakopsora pachyrhizi at 200 ppm when compared under the same conditions with untreated controls that showed significant disease development: P-4, P-37, P-38, P-41, P-43 and P-44.
[0201] Example B8: Puccinia recondita f.sp. tritici / wheat / leaf disc preventative (leaf rust) Wheat leaf slices (cv. Kanzler) are placed on agar in multi-well plates (24-well format) and sprayed with the formulated test compounds diluted in water. One day after application, the leaf slices are inoculated with a fungal spore suspension. The inoculated leaf slices are incubated in a climate cabinet at 19°C and 75% relative humidity under a 12-h light / 12-h dark photoperiod and the activity of the compounds is evaluated as the percentage disease control compared to untreated when an appropriate level of disease damage appears on the untreated test leaf slices (7-9 days after application). The following compounds provided at least 80% control of Puccinia recondita f.sp. tritici at 200 ppm when compared under the same conditions to an untreated control which showed significant disease incidence: P-4, P-5, P-9, P-20, P-22, P-25, P-29, P-34, P-37, P-38, P-39, P-40, P-41, P-43, P-44 and P-45.
[0202] Example B9: Magnaporthe grisea (Pyricularia oryzae) / Rice / Leaf-piece preventative (Rice blast) Rice leaf slices (cv. Ballila) are placed on agar in multi-well plates (24-well format) and sprayed with the formulated test compounds diluted in water. The leaf slices are inoculated with a fungal spore suspension 2 days after application. The inoculated leaf slices are incubated in a climate cabinet at 22°C and 80% relative humidity, with a 24-h darkness followed by a 12-h light / 12-h darkness photoperiod, and the activity of the compounds is evaluated as the percentage disease control compared to untreated when an appropriate level of disease damage appears on the untreated test leaf slices (5-7 days after application). The following compounds provided at least 80% control of Magnaporthe grisea at 200 ppm when compared under the same conditions to an untreated control which showed significant disease incidence: P-5, P-6, P-13, P-14, P-16, P-19, P-20, P-21, P-22, P-23, P-25, P-26, P-28, P-29, P-30, P-34, P-35, P-36, P-37, P-38, P-39, P-40, P-41, P-42, P-43, P-44, P-45, P-47, P-49 and P-50.
[0203] Example B10: Pyrenophora teres / barley / leaf patch preventative (net blotch) Barley leaf slices (cv. Hasso) are placed on agar in multi-well plates (24-well format) and sprayed with the formulated test compounds diluted in water. The leaf slices are inoculated with a fungal spore suspension 2 days after application. The inoculated leaf slices are incubated in a climate cabinet at 20°C and 65% relative humidity under a 12-h light / 12-h dark photoperiod and the activity of the compounds is evaluated as disease control compared to untreated when an appropriate level of disease damage appears on the untreated test leaf slices (5-7 days after application). The following compounds provided at least 80% control of Pyrenophora teres at 200 ppm when compared under the same conditions to untreated controls which showed significant disease incidence: P-5, P-25, P-37, P-38, P-39, P-41, P-43, P-44 and P-45.
[0204] Example B11: Sclerotinia sclerotiorum / liquid culture (cottony rot) Mycelial fragments of freshly grown liquid cultures of the fungus are mixed directly into the nutrient broth (potato dextrose broth). A (DMSO) solution of the test compound is placed in a microtiter plate (96-well format) followed by the addition of the nutrient broth containing the fungal material. The test plates are incubated at 24°C and growth inhibition is measured photometrically 3-4 days after application. The following compounds provided at least 80% control of Sclerotinia sclerotiorum at 20 ppm when compared under the same conditions with untreated controls which showed significant disease development: P-5, P-13, P-20, P-22, P-38 and P-42.
[0205] Example B12: Wheat leaf spot fungus (Mycosphaerella graminicola) (Septoria tritici) / liquid culture (leaf spot) Fungal conidia stored at cryogenic temperatures are mixed directly into nutrient liquid medium (PDB potato dextrose broth). A (DMSO) solution of the test compound is placed in a microtiter plate (96-well format) and then the nutrient liquid medium containing the fungal spores is added. The test plates are incubated at 24°C and growth inhibition is measured photometrically 4-5 days after application. The following compounds provided at least 80% control of Mycosphaerella graminicola at 20 ppm when compared under the same conditions to an untreated control which showed significant disease incidence: P-1, P-2, P-4, P-5, P-9, P-11, P-12, P-13, P-14, P-15, P-16, P-20, P-21, P-22, P-24, P-25, P-29, P-30, P-31, P-32, P-37, P-38, P-39, P-40, P-41, P-42, P-43, P-44, P-45, P-46, P-48 and P-49.
[0206] Example B13: Botryotinia fuckeliana (Botrytis cinerea) / liquid culture (grey mold) Fungal conidia stored at cryogenic temperatures are mixed directly into nutrient liquid medium (Vogels liquid medium). A (DMSO) solution of the test compound is placed in a microtiter plate (96-well format) followed by the addition of nutrient liquid medium containing fungal spores. The test plates are incubated at 24°C and growth inhibition is measured photometrically 3-4 days after application. The following compounds provided at least 80% control of Botryotinia fuckeliana at 20 ppm when compared under the same conditions with untreated controls which showed significant disease development: P-25. Yet another aspect of the present invention may be as follows. [1] Formula (I): [C1] TIFF0007590993000051.tif47146 (In the formula, R 1 is hydrogen, cyano, formyl, C 1 ~C 6 Alkyl carbonyl, C 1 ~C 6 Alkoxycarbonyl, C 1 ~C 6 Haloalkylcarbonyl, C 1 ~C 6 Alkoxy C 1 ~C 6 Alkyl carbonyl, C 3 ~C 6 Cycloalkylcarbonyl, C 1 ~C 6 Alkoxy C 1 ~C 3 Alkoxycarbonyl, C 1 ~C 6 Alkoxyoxalyl, C 1 ~C 6 Alkoxycarbonyl C 1 ~C 4 Alkyl C 1 ~C 6 Alkoxycarbonyl, C 2 ~C 6 Alkenyloxycarbonyl or C 2 ~C 6 alkynyloxycarbonyl; R 2 is hydrogen, C 1 ~C6 Alkyl, C 1 ~C 6 Haloalkyl, halogen, hydroxy, C 1 ~C 6 Alkoxy, C 1 ~C 6 Haloalkoxy, C 3 ~C 6 Cycloalkyloxy, C 3 ~C 6 Halocycloalkyloxy, C 2 ~C 6 Alkenyloxy, C 2 ~C 6 Haloalkenyloxy, C 2 ~C 6 Alkynyloxy, C 2 ~C 6 Haloalkynyloxy, C 1 ~C 6 Cyanoalkyloxy, C 1 ~C 6 Alkoxy C 1 ~C 3 Alkoxy, C 1 ~C 6 Alkoxy C 1 ~C 2 Alkyl, C 2 ~C 6 Alkynyl, C 2 ~C 6 Haloalkynyl or C 3 ~C 6 Cycloalkyl C 1 ~C 2 is alkoxy; R 3 is C 1 ~C 8 Alkyl, C 1 ~C 8 Haloalkyl, C 1 ~C 8 Alkoxy, C 3 ~C 8 Alkynyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Cycloalkyl C 1 ~C 2 Alkyl, Phenyl, Phenyl C 1 ~C 3 Alkyl, Phenoxy C 1 ~C 3 Alkyl, Heteroaryl, HeteroarylC 1 ~C 2 Alkyl, Heteroaryl C 1 ~C 2 Alkoxyimino C 1 ~C 2 alkyl (wherein the heteroaryl is a 5- or 6-membered aromatic monocyclic ring containing 1, 2, 3 or 4 heteroatoms individually selected from N, O and S), heterocyclyl, heterocyclylC 1 ~C 2 alkyl, where the heterocyclyl is a 4-, 5-, or 6-membered non-aromatic monocyclic ring containing 1, 2, or 3 heteroatoms individually selected from N, O, and S, where the cycloalkyl, phenyl, heteroaryl, and heterocyclyl moieties are R 5 or R 6 each optionally substituted with one group represented by 3 When is a substituted heterocyclyl, the ring may be a carbonyl (C=O) or sulfonyl (S(O) 2 ) groups; or R 3 is a 6-10 membered annulated ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N, O and S; R 5 and optionally substituted with one or two groups represented by 1 ~C 2 a 6- to 10-membered annulated ring system optionally attached to the remainder of the molecule through an alkylene linker; or R 3 is a 5-10 membered non-aromatic spirocyclic carbobicyclyl or carbotricyclyl ring system, optionally containing 1, 2, 3, 4 or 5 heteroatoms individually selected from N, O and S; R 5 and optionally substituted with 1 to 3 groups represented by 1 ~C 2 a 5-10 membered non-aromatic spirocyclic carbobicyclyl or carbotricyclyl ring system optionally attached to the remainder of the molecule through an alkylene linker; R 4 is C 1 ~C 8 Alkyl, Hydroxy C 1 ~C 8 Alkyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Cycloalkyl C 1 ~C 2 alkyl, phenyl, heteroaryl, which is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S; heterocyclyl, which is a 4-, 5- or 6-membered non-aromatic monocyclic ring or a 9- to 10-membered non-aromatic bicyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S; wherein the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are selected from R 8 each optionally substituted with 1, 2 or 3 substituents, which may be the same or different, selected from R 5 is a halogen, C 1 ~C 4 Alkyl, C 1 ~C 4 Alkoxy, C 1 ~C 4 Haloalkyl or C 1 ~C 4 haloalkoxy; R 6 is C 1 ~C 4 Alkylsulfonyl, C 3 ~C 8 cycloalkyl, phenyl, benzyl, phenoxy, or pyridyl, where each cycloalkyl, phenyl, or pyridyl group is R 7 and optionally substituted with one group represented by R 7 is a halogen, C 1 ~C 4 Haloalkyl or C 1 ~C 4 haloalkoxy; R 8 is a halogen, C 1 ~C 4 Alkyl, C 1 ~C 4 Alkoxy or C 1 ~C 4 haloalkyl) or a salt or N-oxide thereof. 〔2〕R 1 is hydrogen, cyano, C 1 ~C 3 Alkylcarbonyl or C 1 ~C 2 Alkoxy C 1 ~C 2 The compound according to the above item [1], which is an alkylcarbonyl. 〔3〕R 1 is hydrogen, cyano or acetyl. 〔4〕R 2 is hydrogen, C 1 ~C 4 Alkyl, C 1 ~C 3 Haloalkyl, halogen, hydroxy, C 1 ~C 4 Alkoxy, C 1 ~C 3 Haloalkoxy, C 3 ~C 4 Cycloalkyloxy, C 3 ~C 4 Alkenyloxy, C 3 ~C 4 Alkynyloxy, C 1 ~C 2 Alkoxy C 1 ~C 2 Alkoxy, C 1 ~C 2 Alkoxy C 1 ~C 2 Alkyl, C 1 ~C 3 Haloalkoxy or C 3 ~C 5 The compound according to any one of the above [1] to [3], which is alkynyl. 〔5〕R 3 is C 1 ~C 8 Alkyl, C 3 ~C 7 Alkynyl, C 3 ~C 4 Cycloalkyl, C 3 ~C 4 Cycloalkyl C 1 ~C 2 Alkyl, Phenyl C 1 ~C 3 Alkyl, Phenoxy C 1 ~C 3 Alkyl, Heteroaryl, HeteroarylC 1 ~C 2 Alkyl, Heteroaryl C 1 ~C 2 Alkoxyimino C 1 ~C 2 alkyl (wherein the heteroaryl is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms independently selected from N and O), heterocyclyl, heterocyclylC 1 ~C 2 alkyl, where the heterocyclyl is a 5- or 6-membered non-aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S, where the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are R 5 or one or two groups represented by 6 each optionally substituted with one group represented by 3 When is a substituted heterocyclyl, the ring may be a carbonyl (C=O) or sulfonyl (S(O) 2 ) groups; or R 3 is a 7-9 membered annulated ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N and O; R 5 and optionally substituted with one or two groups represented by 1 ~C 2 a 7- to 9-membered cyclic ring system optionally attached to the remainder of the molecule through an alkylene linker; or R 3 is a 6-9 membered non-aromatic spirocyclic carbobicyclyl ring system, optionally containing 1, 2 or 3 heteroatoms individually selected from N and O; R 5 and optionally substituted with one or two groups represented by 1 ~C 2 The compound according to any one of the above [1] to [4], which is a 6- to 9-membered non-aromatic spirocyclic carbobicyclyl ring system optionally bonded to the remainder of the molecule through an alkylene linker. 〔6〕R 3 is t-butyl, isopentyl, 2,2-dimethylpropyl, 1-methylcyclopropyl, 2,2-dimethylcyclobutyl, or spiro[3.4]octan-3-yl, 〔7〕R 4 is C 1 ~C 6 Alkyl, Hydroxy C 1 ~C 4 Alkyl, C 3 ~C 5 Cycloalkyl, C 3 ~C 4 Cycloalkyl C 1 ~C 2 alkyl, phenyl, heteroaryl, which is a 5- or 6-membered aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from N, O and S, wherein the cycloalkyl, phenyl and heteroaryl moieties are R 8 The compound according to any one of the above [1] to [6], each of which may be optionally substituted with 1 or 2 substituents, which may be the same or different, selected from: 〔8〕R 4 is C 1 ~C 6 Alkyl, Hydroxy C 1 ~C 4 Alkyl, C 3 ~C 5 Cycloalkyl, C 3 ~C 4 Cycloalkyl C 1 ~C 2 alkyl, phenyl, heteroaryl, which is a 5- or 6-membered aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from N, O and S, wherein the cycloalkyl, phenyl and heteroaryl moieties are R 8 The compound according to any one of the above [1] to [7], each of which may be optionally substituted with 1 or 2 substituents, which may be the same or different, selected from: 〔9〕R 5 is chloro, fluoro, methyl, difluoromethyl or trifluoromethyl, 〔10〕R 6 is cyclopropyl, phenyl, phenoxy or pyridyl, where each cyclopropyl, phenyl or pyridyl group is 7 The compound according to any one of the above [1] to [9], which may be optionally substituted with one group represented by: 〔11〕R 7 is chloro, fluoro, trifluoromethyl or trifluoromethoxy.
[12] An agricultural chemical composition comprising a fungicidally effective amount of a compound of formula (I) according to any one of [1] to
[11] above.
[13] The composition according to
[12] , further comprising at least one additional active ingredient and / or an agriculturally acceptable diluent or carrier.
[14] A method for controlling or preventing infestation of a useful plant by a phytopathogenic microorganism, comprising applying a fungicidally effective amount of a compound of formula (I) described in any one of [1] to
[11] above or a composition described in
[12] or
[13] above to the plant, a part thereof, or a habitat thereof.
[15] Use of the compound of formula (I) according to any one of the above [1] to
[11] as a bactericide or fungicide.
Claims
1. Formula (I): 【Chemistry 1】 (In the formula, R 1 is hydrogen, cyano, or acetyl; R 2 is C 1 ~C4 alkyl, C 1 ~C3 haloalkyl, halogen, hydroxy, C 1 ~C4 alkoxy, C 1 ~C3 haloalkoxy, C 3 ~C4 cycloalkyloxy, C3-C4 alkenyloxy, C3-C4 alkynyloxy, C 1 ~C2 alkoxy C 1 ~C2 alkoxy, C 1 ~C2 alkoxy C 1 ~C 2 alkyl, or C3-C5 alkynyl; R 3 is t-butyl, isopentyl, 2,2-dimethylpropyl, 1-methylcyclopropyl, 2,2-dimethylcyclobutyl or spiro[3.4]octan-3-yl; R 4 is C 1 ~C 8 Alkyl, Hydroxy C 1 ~C 8 Alkyl, C 3 ~C 8 Cycloalkyl, C 3 ~C 8 Cycloalkyl C 1 ~C 2 alkyl, phenyl, heteroaryl, which is a 5- or 6-membered aromatic monocyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S; heterocyclyl, which is a 4-, 5- or 6-membered non-aromatic monocyclic ring or a 9-10-membered non-aromatic bicyclic ring containing 1, 2 or 3 heteroatoms individually selected from N, O and S; wherein the cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are selected from R 8 each optionally substituted with 1, 2 or 3 substituents, which may be the same or different, selected from R 8 is halogen, C 1 ~C 4 Alkyl, C 1 ~C 4 Alkoxy or C 1 ~C 4 haloalkyl) Compounds of P-46: 【change】 Compounds of P-48: 【change】 or P-49: 【change】 Compounds of or a salt or N-oxide thereof.
2. R 4 is C 1 ~C 6 Alkyl, Hydroxy C 1 ~C 4 Alkyl, C 3 ~C 5 Cycloalkyl, C 3 ~C 4 Cycloalkyl C 1 ~C 2 alkyl, phenyl, heteroaryl, which is a 5- or 6-membered aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from N, O and S, wherein the cycloalkyl, phenyl and heteroaryl moieties are R 8 2. The compound according to claim 1, or a salt or N-oxide thereof, each optionally substituted with one or two substituents, which may be the same or different, selected from:
3. R 4 is C 1 ~C 6 Alkyl, Hydroxy C 1 ~C 4 Alkyl, C 3 ~C 5 Cycloalkyl, C 3 ~C 4 Cycloalkyl C 1 ~C 2 alkyl, phenyl, heteroaryl, which is a 5- or 6-membered aromatic monocyclic ring containing 1 or 2 heteroatoms independently selected from N, O and S, wherein the cycloalkyl, phenyl and heteroaryl moieties are R 8 3. The compound according to claim 1 or 2, or a salt or N-oxide thereof, each optionally substituted with one or two substituents, which may be the same or different, selected from:
4. 4. An agrochemical composition comprising a fungicidally effective amount of a compound according to any one of claims 1 to 3, or a salt or N-oxide thereof.
5. 5. The composition of claim 4, further comprising at least one additional active ingredient and / or an agronomically acceptable diluent or carrier.
6. A method for controlling or preventing infestation of useful plants by phytopathogenic microorganisms, comprising applying a fungicidally effective amount of a compound according to any one of claims 1 to 3, or a salt or N-oxide thereof, or a composition according to claim 4 or 5 to said plant, a part thereof or its habitat.
7. Use of the compound according to any one of claims 1 to 3 or its salt or N-oxide as a bactericide or fungicide, excluding medical treatment for humans.
Citation Information
Patent Citations
Pirajinjudotai no seiho
JP1975105675A
Pyrazine derivative
JP1987153284A
Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenylamines and their use as pharmaceuticals
JP2004518720A
Acylated arylcycloalkylamines and their use as pharmaceuticals
JP2005534706A
Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
JP2005538123A
